H322 Nuclear N4 30609389,11/893,4.92420329516326E-08,2.2651335157751E-06,0,0,11.9023242630385,200.27467642817,TLE4;ATF7IP;KDM3A;MBD5;CHD9;MAX;CTR9;TET2;EP300;TLK1;PADI4,,,,,,,,,,
DYRK1A human kinase ARCHS4 coexpression,8/299,1.329697437117E-08,3.0184131822556E-06,0,0,23.5206932616166,426.564926375867,ATF7IP;KDM3A;PRKCB;KAT6A;USP12;EP300;NAP1L1;STK4,,,,,,,,,,
Chromatin organization Homo sapiens R-HSA-4839726,7/226,4.47537375615774E-08,5.81798588300506E-06,0,0,26.3032724505327,445.10636671212,ATF7IP;KDM3A;KMT2A;KAT6A;EP300;PADI4;JAK2,,,,,,,,,,
Chromatin modifying enzymes Homo sapiens R-HSA-3247509,7/226,4.47537375615774E-08,5.81798588300506E-06,0,0,26.3032724505327,445.10636671212,ATF7IP;KDM3A;KMT2A;KAT6A;EP300;PADI4;JAK2,,,,,,,,,,
GRK3 human kinase ARCHS4 coexpression,7/299,3.00782271883643E-07,2.27591919058624E-05,0,0,19.6545376712329,295.149817609861,MBD5;PRKCB;KAT6A;EP300;ARRB1;STK4;JAK2,,,,,,,,,,
RIOK3 human kinase ARCHS4 coexpression,7/299,3.00782271883643E-07,2.27591919058624E-05,0,0,19.6545376712329,295.149817609861,GFI1B;MAX;USP12;UIMC1;TET2;STK4;JAK2,,,,,,,,,,
Human betaherpesvirus 6B Phosphotransferase (gene: U69),9/489,3.62438385133049E-08,9.23855443704143E-05,0,0,16.6099431818182,284.578097438228,PRKAB2;PRKCB;CTR9;UIMC1;PRKCD;EP300;TLK1;STK4;JAK2,,,,,,,,,,
Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),8/404,1.35833804015648E-07,0.000115413455479,0,0,17.1919191919192,271.835767724292,PRKAB2;PRKCB;CTR9;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Human herpesvirus 4 type 2 BGLF4,8/404,1.35833804015648E-07,0.000115413455479,0,0,17.1919191919192,271.835767724292,PRKAB2;PRKCB;CTR9;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Wnt signaling pathway Homo sapiens P00057,6/278,3.75669060570729E-06,0.000127727480594,0,0,17.3797058823529,217.106801791251,TLE4;CDH1;PRKCB;PRKCD;EP300;ARRB1,,,,,,,,,,
RIPK4,2/2,2.32492970487224E-06,0.000130196063473,0,0,39938,518068.577267085,PRKCB;PRKCD,,,,,,,,,,
Non-genomic actions of 1 25 dihydroxyvitamin D3 WP4341,3/71,0.000179430714858,0.002637631508411,0,0,31.3566176470588,270.473448315081,VDR;PRKCB;PRKCD,,,,,,,,,,
Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),10/833,2.97557569774043E-07,0.000189618561339,0,0,11.0779378580108,166.475462791898,PRKAB2;PRKCB;ZMYND8;CTR9;UIMC1;PRKCD;EP300;TLK1;STK4;JAK2,,,,,,,,,,
PHLPP1,2/6,3.4740333438573E-05,0.000208442000631,0,0,344.224137931034,3534.35892516632,PRKCB;STK4,,,,,,,,,,
PHLPP2,2/6,3.4740333438573E-05,0.000208442000631,0,0,344.224137931034,3534.35892516632,PRKCB;STK4,,,,,,,,,,
EP300,7/357,9.89824175596284E-07,0.000208852901051,0,0,16.3491666666667,226.039303189715,MAX;CDH1;VDR;ZBTB16;PRKCD;EP300;NAP1L1,,,,,,,,,,
Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),10/872,4.53565573403677E-07,0.000231227729321,0,0,10.5551872721246,154.170395079144,PRKAB2;PRKCB;ZMYND8;CTR9;UIMC1;PRKCD;EP300;TLK1;STK4;JAK2,,,,,,,,,,
MARK3 human kinase ARCHS4 coexpression,6/299,5.70684968116517E-06,0.000259090975525,0,0,16.1168600682594,194.59244466276,MBD5;KMT2A;KAT6A;USP12;EP300;JAK2,,,,,,,,,,
BRAF human kinase ARCHS4 coexpression,6/299,5.70684968116517E-06,0.000259090975525,0,0,16.1168600682594,194.59244466276,KDM3A;KMT2A;CHD9;KAT6A;TET2;EP300,,,,,,,,,,
HCC827 Nuclear N4 30609389,9/981,1.20089408969443E-05,0.00026782663341,0,0,7.99537037037037,90.5864198354513,ATF7IP;KDM3A;MBD5;CHD9;MAX;CTR9;TET2;EP300;TLK1,,,,,,,,,,
MCF7 Nuclear N4 30609389,9/1028,1.74669543527974E-05,0.00026782663341,0,0,7.60772593451691,83.3441575211012,TLE4;ATF7IP;KDM3A;CHD9;MAX;CTR9;TET2;EP300;TLK1,,,,,,,,,,
up HS+LS 30min LPS vs ctrl RAW264.7 macrophage (Mouse) [20222745],4/86,9.17488712659463E-06,0.000347833671954,0,0,35.929539295393,416.748180225575,PRKAB2;PRKCD;TLK1;STK4,,,,,,,,,,
up HS+LS 90min LPS vs ctrl RAW264.7 macrophage (Mouse) [20222745],4/92,1.19942645501382E-05,0.000347833671954,0,0,33.469696969697,379.247880095193,PRKAB2;PRKCD;TLK1;STK4,,,,,,,,,,
Signaling by NOTCH1 Homo sapiens R-HSA-1980143,4/72,4.51263204941416E-06,0.000391094777616,0,0,43.3572984749455,533.66894350089,TLE4;HDAC5;EP300;ARRB1,,,,,,,,,,
Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),7/377,1.42372505048677E-06,0.000431922664296,0,0,15.4496621621622,207.986964870898,PRKAB2;PRKCB;CTR9;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Cowpox virus CPXV057 protein (gene: CPXV057 CDS),7/387,1.69447887130663E-06,0.000431922664296,0,0,15.0354166666667,199.792651183487,PRKAB2;PRKCB;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),8/538,1.18955801167143E-06,0.000431922664296,0,0,12.7573420836751,174.034751599406,PRKAB2;PRKCB;CTR9;PRKCD;EP300;TLK1;STK4;JAK2,,,,,,,,,,
Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),9/767,1.61462716986348E-06,0.000431922664296,0,0,10.3681338450468,138.273647422658,PRKAB2;PRKCB;CTR9;UIMC1;PRKCD;EP300;TLK1;STK4;JAK2,,,,,,,,,,
Pathways affected in adenoid cystic carcinoma WP3651,4/65,2.99226664143657E-06,0.000439863196291,0,0,48.3497267759563,614.983352934093,MAX;KAT6A;EP300;TLK1,,,,,,,,,,
Horsepox virus HSPV189 (Serine/threonine protein kinase),5/139,2.21613854882257E-06,0.000442730513102,0,0,28.4658438576349,370.618007427742,PRKCB;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L),6/250,2.03526462331954E-06,0.000442730513102,0,0,19.4016393442623,254.256246820551,PRKCB;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Horsepox virus HSPV050 (Ser/Thr kinase; Provisional),7/414,2.64949779292157E-06,0.000442730513102,0,0,14.0186322686323,180.015225850805,PRKAB2;PRKCB;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Vaccinia virus Ankara Serine/threonine-protein kinase 2,7/414,2.64949779292157E-06,0.000442730513102,0,0,14.0186322686323,180.015225850805,PRKAB2;PRKCB;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),7/417,2.77900675152177E-06,0.000442730513102,0,0,13.9139227642276,178.006615718666,PRKAB2;PRKCB;CTR9;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),9/816,2.68960848377323E-06,0.000442730513102,0,0,9.71375464684015,124.589733405143,PRKAB2;PRKCB;CTR9;UIMC1;PRKCD;EP300;TLK1;STK4;JAK2,,,,,,,,,,
Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),7/424,3.10193734938364E-06,0.000465108135505,0,0,13.6754596322942,173.452469203011,PRKAB2;PRKCB;CTR9;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Variola virus Ser/Thr kinase (gene: C14L),7/429,3.35134246662172E-06,0.000474587330412,0,0,13.5099723538705,170.308731991609,PRKAB2;PRKCB;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Vaccinia virus Ser/Thr kinase (gene: F10L),7/439,3.90070014967525E-06,0.000502480572478,0,0,13.1904899691358,164.27903804342,PRKAB2;PRKCB;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),9/855,3.94257020382679E-06,0.000502480572478,0,0,9.24709864603482,115.067915316193,PRKAB2;PRKCB;CTR9;UIMC1;PRKCD;EP300;TLK1;STK4;JAK2,,,,,,,,,,
Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),7/450,4.5899964567618E-06,0.000531813680377,0,0,12.8557185854026,158.017753023396,PRKAB2;PRKCB;CTR9;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),9/868,4.4593825263791E-06,0.000531813680377,0,0,9.10096306487459,112.128417702533,PRKAB2;PRKCB;CTR9;UIMC1;PRKCD;EP300;TLK1;STK4;JAK2,,,,,,,,,,
Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),7/456,5.00699215699052E-06,0.000554905348181,0,0,12.6800296956199,154.755643847613,PRKAB2;PRKCB;CTR9;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),7/463,5.53301483119699E-06,0.000564146192189,0,0,12.4809027777778,151.078553789474,PRKCB;CTR9;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Human herpesvirus 3 strain Dumas serine-threonine protein kinase,9/887,5.31949988704183E-06,0.000564146192189,0,0,8.89516463035825,108.024046896855,PRKAB2;PRKCB;CTR9;UIMC1;PRKCD;EP300;TLK1;STK4;JAK2,,,,,,,,,,
PPP2CA,5/184,8.73338919400582E-06,0.000566302304202,0,0,21.2612806188225,247.658987767716,HDAC5;VDR;PRKCB;PRKCD;JAK2,,,,,,,,,,
STAT3,5/192,1.07355887052446E-05,0.000566302304202,0,0,20.3434800493624,232.76900604268,PRKCB;CTR9;PRKCD;EP300;JAK2,,,,,,,,,,
TP53,7/502,9.38295662338435E-06,0.000566302304202,0,0,11.4745791245791,132.836792150985,VDR;PRKCB;PRKCD;EP300;NAP1L1;PADI4;STK4,,,,,,,,,,
Parathyroid hormone synthesis  secretion and action,3/106,0.000583841527305,0.012154901046561,0,0,20.6650485436893,153.869491681428,VDR;PRKCB;ARRB1,,,,,,,,,,
U251 Nuclear N4 30609389,8/903,5.22404457280443E-05,0.000600765125873,0,0,7.41277629341754,73.0874060279539,TLE4;ATF7IP;KDM3A;MAX;CTR9;TET2;EP300;TLK1,,,,,,,,,,
Platelet activation  signaling and aggregation Homo sapiens R-HSA-76002,4/253,0.000601385536993,0.019545029952275,0,0,11.7328573553473,87.0140888994092,PRKCB;PRKCD;ARRB1;JAK2,,,,,,,,,,
UBC,7/540,1.50618502113176E-05,0.000635610078918,0,0,10.6357098186366,118.091960617306,HDAC5;CDH1;PRKCB;ZBTB16;UIMC1;ARRB1;JAK2,,,,,,,,,,
Human gammaherpesvirus 8 ORF36 (gene: ORF36),7/480,7.00539619106535E-06,0.000679570614229,0,0,12.0218463706836,142.685248713258,PRKAB2;PRKCB;CTR9;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Ectromelia virus ERPV serine/threonine kinase,7/482,7.19827641592425E-06,0.000679570614229,0,0,11.97,141.744777298906,PRKAB2;PRKCB;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
CSNK2A2,5/229,2.51043257088004E-05,0.000702921119846,0,0,16.951407967033,179.557286920265,MAX;CDH1;VDR;CTR9;STK4,,,,,,,,,,
Growth hormone synthesis, secretion and action,3/119,0.000817467682061,0.01410131751555,0,0,18.3371305418719,130.364147282977,PRKCB;EP300;JAK2,,,,,,,,,
Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),7/508,1.01368106793706E-05,0.000922811800776,0,0,11.3336660013307,130.329646358081,PRKAB2;PRKCB;CTR9;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Proteins Involved in Myocardial Ischemia,6/252,2.13136623923395E-06,0.00097403437133,0,0,19.2419512195122,251.275779631305,KMT2A;PRKCB;PRKCD;ARRB1;STK4;JAK2,,,,,,,,,,
CHEK1,4/137,5.74254416408117E-05,0.001071941577295,0,0,22.0952380952381,215.760510812684,CTR9;UIMC1;TLK1;STK4,,,,,,,,,,
Kisspeptin/kisspeptin receptor system in the ovary WP4871,3/39,2.96697065366535E-05,0.001090361715222,0,0,59.3244047619048,618.479701081729,PRKCB;PRKCD;ARRB1,,,,,,,,,,
Pathways Regulating Hippo Signaling WP4540,4/98,1.54060187419362E-05,0.001090361715222,0,0,31.3238770685579,347.092122794011,PRKAB2;CDH1;PRKCB;PRKCD,,,,,,,,,,
Gastrin signaling pathway WP4659,4/114,2.7971628383641E-05,0.001090361715222,0,0,26.7461279461279,280.414959695159,CDH1;PRKCD;ARRB1;JAK2,,,,,,,,,,
Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),7/534,1.40118853674295E-05,0.001231596406951,0,0,10.7601201771031,120.250848910305,PRKAB2;PRKCB;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
HIST1H3A,4/122,3.65018391774422E-05,0.001283648011073,0,0,24.9227871939736,254.664725883014,PRKCD;EP300;TLK1;JAK2,,,,,,,,,,
Yaba monkey tumor virus 142R,6/357,1.56594015161366E-05,0.001330527148821,0,0,13.4140170940171,148.418575028504,PRKCB;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
ROCK1 human kinase ARCHS4 coexpression,5/299,8.92019595401392E-05,0.001557603447355,0,0,12.8695709052852,120.003698037445,KAT6A;TET2;EP300;STK4;JAK2,,,,,,,,,,
CLK1 human kinase ARCHS4 coexpression,5/299,8.92019595401392E-05,0.001557603447355,0,0,12.8695709052852,120.003698037445,ATF7IP;KDM3A;KAT6A;TET2;STK4,,,,,,,,,,
MAPK6 human kinase ARCHS4 coexpression,5/299,8.92019595401392E-05,0.001557603447355,0,0,12.8695709052852,120.003698037445,PRKAB2;CDH1;ZMYND8;NAP1L1;JARID2,,,,,,,,,,
STRADB human kinase ARCHS4 coexpression,5/299,8.92019595401392E-05,0.001557603447355,0,0,12.8695709052852,120.003698037445,GFI1B;MAX;USP12;STK4;JAK2,,,,,,,,,,
ATM human kinase ARCHS4 coexpression,5/299,8.92019595401392E-05,0.001557603447355,0,0,12.8695709052852,120.003698037445,PRKCB;KAT6A;TET2;STK4;JAK2,,,,,,,,,,
PIK3CA human kinase ARCHS4 coexpression,5/299,8.92019595401392E-05,0.001557603447355,0,0,12.8695709052852,120.003698037445,KDM3A;KAT6A;USP12;STK4;JAK2,,,,,,,,,,
PIK3CG human kinase ARCHS4 coexpression,5/299,8.92019595401392E-05,0.001557603447355,0,0,12.8695709052852,120.003698037445,MAX;PRKCB;PRKCD;STK4;JAK2,,,,,,,,,,
SMG1 human kinase ARCHS4 coexpression,5/299,8.92019595401392E-05,0.001557603447355,0,0,12.8695709052852,120.003698037445,MBD5;KMT2A;KAT6A;EP300;STK4,,,,,,,,,,
Signaling by NOTCH1,4/73,4.76908113176592E-06,0.001612607142261,0,0,42.7267847557703,523.546543078392,TLE4;HDAC5;EP300;ARRB1,,,,,,,,,,
Pathways in cancer,6/325,9.18864468524968E-06,0.001612607142261,0,0,14.7836990595611,171.454572378831,MAX;CDH1;PRKCB;ZBTB16;EP300;STK4,,,,,,,,,,
IFN-gamma pathway Homo sapiens 51b1ed75-6193-11e5-8ac5-06603eb7f303,3/40,3.2041735322371E-05,0.001704973982936,0,0,57.7181467181467,597.294583422934,PRKCD;EP300;JAK2,,,,,,,,,,
PAR1-mediated thrombin signaling events Homo sapiens be5084c0-6194-11e5-8ac5-06603eb7f303,3/43,3.98972526867493E-05,0.001704973982936,0,0,53.38125,540.70952252321,PRKCB;PRKCD;ARRB1,,,,,,,,,,
Role of Calcineurin-dependent NFAT signaling in lymphocytes Homo sapiens 61bdd46d-6195-11e5-8ac5-06603eb7f303,3/53,7.49439113378306E-05,0.001704973982936,0,0,42.6835714285714,405.441452237765,PRKCB;PRKCD;EP300,,,,,,,,,,
Validated transcriptional targets of TAp63 isoforms Homo sapiens 82e8ee19-6196-11e5-8ac5-06603eb7f303,3/53,7.49439113378306E-05,0.001704973982936,0,0,42.6835714285714,405.441452237765,VDR;PRKCD;EP300,,,,,,,,,,
STAT1,4/139,6.07605478471601E-05,0.001741422363645,0,0,21.7657064471879,211.313881675338,VDR;PRKCD;EP300;JAK2,,,,,,,,,,
NCOR1,4/142,6.60254924604572E-05,0.001741422363645,0,0,21.2893183038111,204.919687013305,HDAC5;VDR;ZBTB16;EP300,,,,,,,,,,
CSNK2A2,5/289,7.59839643270796E-05,0.001781401830335,0,0,13.3294962080173,126.430114720012,MAX;CDH1;VDR;CTR9;STK4,,,,,,,,,,
PRKDC,5/296,8.50638354632015E-05,0.001794846928274,0,0,13.0042294475284,121.877050354005,KDM3A;PRKAB2;PRKCB;ZMYND8;PRKCD,,,,,,,,,,
Banna virus strain JKT-6423 Vp7,4/108,2.26105050803735E-05,0.001818409064139,0,0,28.2977207977208,302.703434061843,PRKCB;EP300;STK4;JAK2,,,,,,,,,,
Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),7/576,2.2828203237525E-05,0.001818409064139,0,0,9.94434680726421,106.280343757856,PRKAB2;PRKCB;CTR9;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Pathways in cancer,7/531,1.35101608581076E-05,0.001864402198419,0,0,10.8233937659033,121.352632300016,MAX;CDH1;PRKCB;ZBTB16;EP300;STK4;JAK2,,,,,,,,,,
IRS1,4/157,9.74772884508838E-05,0.001869791623922,0,0,19.1876059065602,177.214639506493,CDH1;PRKCB;PRKCD;JAK2,,,,,,,,,,
BMAL1:CLOCK,NPAS2 activates circadian gene expression Homo sapiens R-HSA-1368108,2/42,0.001926036125594,0.029457023097316,0,0,34.3603448275862,214.830881903165,CHD9;EP300,,,,,,,,,
RAF1,4/166,0.000120900948358,0.001962315392579,0,0,18.1133973479653,163.392606406856,PRKCB;PRKCD;ARRB1;JAK2,,,,,,,,,,
SRC,6/513,0.000117978212245,0.001962315392579,0,0,9.21278106508876,83.3297023204679,CDH1;VDR;PRKCD;EP300;ARRB1;JAK2,,,,,,,,,,
TNFRSF1A,4/173,0.00014175659562,0.001976602324828,0,0,17.3570019723866,153.807321422367,PRKCB;PRKCD;NAP1L1;JAK2,,,,,,,,,,
SMAD3,5/328,0.0001377171025,0.001976602324828,0,0,11.6968325791855,103.988455468097,HDAC5;MAX;VDR;ZBTB16;EP300,,,,,,,,,,
CREBBP,5/334,0.00014988453648,0.001976602324828,0,0,11.4800093523498,101.088890593598,CDH1;VDR;PRKCD;EP300;NAP1L1,,,,,,,,,,
PPP1CA,4/184,0.000179632342107,0.001994864430764,0,0,16.2872427983539,140.470927198005,MAX;CDH1;VDR;PRKCD,,,,,,,,,,
HDAC1,5/346,0.000176681521478,0.001994864430764,0,0,11.0692533273178,95.6512085613811,TLE4;CDH1;ZBTB16;EP300;PADI4,,,,,,,,,,
MAPK14,6/552,0.00017590813507,0.001994864430764,0,0,8.53758241758242,73.8120842216381,KDM3A;MAX;PRKCB;ZMYND8;CTR9;ARRB1,,,,,,,,,,
CCKR signaling map ST Homo sapiens P06959,4/165,0.00011811514176,0.002007957409917,0,0,18.2268230963883,164.84066557296,CDH1;PRKCB;PRKCD;JAK2,,,,,,,,,,
AKT1,5/355,0.000199077120154,0.002100263617626,0,0,10.7796703296703,91.8623915583513,PRKCB;PRKCD;EP300;ARRB1;STK4,,,,,,,,,,
Endothelins Homo sapiens dfb9dc47-6191-11e5-8ac5-06603eb7f303,3/63,0.000125717424492,0.002190256311649,0,0,35.5517857142857,319.307433084775,PRKCB;PRKCD;JAK2,,,,,,,,,,
Signaling events mediated by HDAC Class I Homo sapiens 97e84126-6195-11e5-8ac5-06603eb7f303,3/66,0.000144412504065,0.002190256311649,0,0,33.8537414965986,299.363109160574,HDAC5;MAX;EP300,,,,,,,,,,
SP1,4/195,0.000224337974422,0.002237116446516,0,0,15.340701958503,128.89805186024,ATF7IP;ZBTB16;EP300;NAP1L1,,,,,,,,,,
MDM2,4/197,0.000233253847504,0.002237116446516,0,0,15.1801957397812,126.957794374658,CDH1;EP300;ARRB1;NAP1L1,,,,,,,,,,
Kit receptor signaling pathway WP304,3/59,0.00010334978312,0.002358737566391,0,0,38.0988520408163,349.648075939072,PRKCB;EP300;JAK2,,,,,,,,,,
Oncostatin M Signaling Pathway WP2374,3/65,0.000137992883954,0.002358737566391,0,0,34.4014976958525,305.771122307878,PRKCB;PRKCD;JAK2,,,,,,,,,,
AGE/RAGE pathway WP2324,3/66,0.000144412504065,0.002358737566391,0,0,33.8537414965986,299.363109160574,PRKCB;PRKCD;JAK2,,,,,,,,,,
Integrated breast cancer pathway WP1984,4/152,8.59942969045159E-05,0.002358737566391,0,0,19.8408408408408,185.734666150984,MAX;CDH1;ZMYND8;EP300,,,,,,,,,,
Chemokine signaling pathway WP3929,4/164,0.000115376258401,0.002358737566391,0,0,18.3416666666667,166.309613499011,PRKCB;PRKCD;ARRB1;JAK2,,,,,,,,,,
Signaling by NOTCH Homo sapiens R-HSA-157118,4/122,3.65018391774422E-05,0.002372619546534,0,0,24.9227871939736,254.664725883014,TLE4;HDAC5;EP300;ARRB1,,,,,,,,,,
down HS+LS 3min LPS vs ctrl RAW264.7 macrophage (Mouse) [20222745],3/65,0.000137992883954,0.002667862423115,0,0,34.4014976958525,305.771122307878,PRKAB2;PRKCD;TLK1,,,,,,,,,,
RB1,4/209,0.000292207367764,0.002680684982531,0,0,14.2829268292683,116.235127608402,VDR;PRKCB;ZBTB16;EP300,,,,,,,,,,
UBE2I,4/212,0.000308476002225,0.002687552173658,0,0,14.0747863247863,113.778693753101,ATF7IP;HDAC5;UIMC1;EP300,,,,,,,,,,
HDAC2,4/214,0.000319677106137,0.002687552173658,0,0,13.9393298059965,112.186501807185,CDH1;VDR;ZBTB16;PADI4,,,,,,,,,,
BRCA1,4/216,0.000331167566422,0.002687552173658,0,0,13.80642907058,110.629343144575,GFI1B;UIMC1;EP300;JAK2,,,,,,,,,,
NOTCH1 Intracellular Domain Regulates Transcription Homo sapiens R-HSA-2122947,3/47,5.22020716606151E-05,0.002714507726352,0,0,48.5186688311688,478.412918204461,TLE4;HDAC5;EP300,,,,,,,,,,
FLT3/KIT/MLL Signaling in Leukemia,3/29,1.19877594199572E-05,0.00273920302746,0,0,82.1826923076923,931.263407749183,KMT2A;KAT6A;JAK2,,,,,,,,,,
Signaling by NOTCH,4/119,3.31071041852435E-05,0.002905148392255,0,0,25.5768115942029,263.84431827792,TLE4;HDAC5;EP300;ARRB1,,,,,,,,,,
Wnt signaling pathway,5/231,2.61730066616216E-05,0.002905148392255,0,0,16.7996936691627,177.249904871103,TLE4;PRKCB;PRKCD;EP300;ARRB1,,,,,,,,,,
Regulation of nuclear beta catenin signaling and target gene transcription Homo sapiens 1590a3b3-6195-11e5-8ac5-06603eb7f303,3/79,0.000246185449543,0.00301504119538,0,0,28.0446428571429,233.034868984202,TLE4;CDH1;EP300,,,,,,,,,,
Regulation of nuclear SMAD2/3 signaling Homo sapiens 246aac04-6195-11e5-8ac5-06603eb7f303,3/81,0.000265058566627,0.00301504119538,0,0,27.3228021978022,225.01857004446,MAX;VDR;EP300,,,,,,,,,,
A431 Nuclear N4 30609389,7/884,0.000333412369997,0.00306739380397,0,0,6.34948688711517,50.8348205359059,ATF7IP;KDM3A;CHD9;CTR9;TET2;EP300;TLK1,,,,,,,,,,
Regulation of transcription by NOTCH1 intracellular domain,3/47,5.22020716606151E-05,0.003353777579276,0,0,48.5186688311688,478.412918204461,TLE4;HDAC5;EP300,,,,,,,,,,
Kit receptor signaling pathway,3/54,7.92692117607805E-05,0.003353777579276,0,0,41.8445378151261,395.12377503346,PRKCB;EP300;JAK2,,,,,,,,,,
Calcineurin-dependent NFAT signaling role in lymphocytes,3/55,8.37545664890234E-05,0.003353777579276,0,0,41.0377747252747,385.24702916497,PRKCB;PRKCD;EP300,,,,,,,,,,
TAp63 pathway,3/55,8.37545664890234E-05,0.003353777579276,0,0,41.0377747252747,385.24702916497,VDR;PRKCD;EP300,,,,,,,,,,
Integrated breast cancer pathway,4/152,8.59942969045159E-05,0.003353777579276,0,0,19.8408408408408,185.734666150984,MAX;CDH1;ZMYND8;EP300,,,,,,,,,,
Molluscum contagiosum virus subtype 1 MC017L (gene: MC017L),5/260,4.60358464199373E-05,0.003555920379528,0,0,14.867269984917,148.465899022051,PRKCB;CTR9;PRKCD;EP300;STK4,,,,,,,,,,
Attenuation of GPCR signaling,2/11,0.000126768471346,0.00355757510937,0,0,152.950191570881,1372.444735506,PRKCB;ARRB1,,,,,,,,,,
Angiotensin II-stimulated signaling through G-proteins and beta-arrestin,3/64,0.000131762041088,0.00355757510937,0,0,34.9672131147541,312.415019492367,PRKCB;PRKCD;ARRB1,,,,,,,,,,
Endothelins,3/64,0.000131762041088,0.00355757510937,0,0,34.9672131147541,312.415019492367,PRKCB;PRKCD;JAK2,,,,,,,,,,
MAPK signaling pathway,5/314,0.000112275114735,0.00355757510937,0,0,12.235499128703,111.276460364575,MAX;PRKCB;PRKCD;ARRB1;STK4,,,,,,,,,,
Glioblastoma signaling pathways WP2261,3/82,0.000274835936022,0.003672807508655,0,0,26.9755877034358,221.181913706857,PRKCB;PRKCD;EP300,,,,,,,,,,
YWHAG,5/428,0.000470653290276,0.003678068305489,0,0,8.88616112020367,68.0803357174301,HDAC5;PRKCB;PRKCD;ARRB1;STK4,,,,,,,,,,
CAMK4,2/17,0.000311653957678,0.003693822684987,0,0,91.7425287356322,740.694048400672,HDAC5;EP300,,,,,,,,,,
MAPK14,5/396,0.000329805596874,0.003693822684987,0,0,9.62915601023018,77.19701284703,MAX;PRKCB;ZMYND8;CTR9;ARRB1,,,,,,,,,,
up HS+LS 3min LPS vs ctrl RAW264.7 macrophage (Mouse) [20222745],3/81,0.000265058566627,0.003843349216089,0,0,27.3228021978022,225.01857004446,PRKAB2;PRKCD;STK4,,,,,,,,,,
Platelet activation, signaling and aggregation,3/205,0.003860979947981,0.027657223709006,0,0,10.4846181046676,58.2612850366196,PRKCB;PRKCD;ARRB1,,,,,,,,,
CAMK1,2/20,0.000434140102652,0.003865848279055,0,0,76.4406130268199,591.814176843113,HDAC5;EP300,,,,,,,,,,
PRKCD,3/104,0.000552264039865,0.003865848279055,0,0,21.0763790664781,158.104126519724,HDAC5;PRKCD;EP300,,,,,,,,,,
PRKCA,5/442,0.00054487707512,0.003865848279055,0,0,8.59531772575251,64.593385856786,VDR;PRKCB;ZMYND8;PRKCD;EP300,,,,,,,,,,
ACTG1,4/246,0.000541248177746,0.004078691625155,0,0,12.0765228037955,90.835168164006,ATF7IP;CDH1;PRKCB;PRKCD,,,,,,,,,,
up HS+LS 10min LPS vs ctrl RAW264.7 macrophage (Mouse) [20222745],3/90,0.000361542706024,0.004193895389883,0,0,24.4852216748768,194.048574345848,PRKAB2;PRKCD;STK4,,,,,,,,,,
Cowpox virus CPXV206 protein (gene: CPXV206 CDS),5/271,5.60491185748245E-05,0.004202035389624,0,0,14.2445054945055,139.443483148791,PRKCB;CTR9;PRKCD;EP300;JAK2,,,,,,,,,,
Signaling events mediated by HDAC class I,3/70,0.00017202935987,0.004313021808168,0,0,31.8262260127932,275.864806706144,HDAC5;MAX;EP300,,,,,,,,,,
GSK3B,6/696,0.000607998634788,0.004423714204834,0,0,6.70573913043478,49.6582642737308,CDH1;PRKCB;ZMYND8;CTR9;UIMC1;PRKCD,,,,,,,,,,
Chemokine signaling pathway,4/189,0.00019906522321,0.004658126223122,0,0,15.843043043043,135.012480470341,PRKCB;PRKCD;ARRB1;JAK2,,,,,,,,,,
Corticotropin-releasing hormone signaling pathway WP2355,3/93,0.000398099569736,0.004876719729264,0,0,23.6654761904762,185.27247899714,PRKCB;PRKCD;ARRB1,,,,,,,,,,
B Cell Receptor Signaling Pathway WP23,3/97,0.000450429125066,0.005093313952665,0,0,22.6538753799392,174.555128388526,MAX;PRKCB;PRKCD,,,,,,,,,,
Wnt signaling pathway and pluripotency WP399,3/102,0.000521803733075,0.005304232141907,0,0,21.504329004329,162.534428730717,PRKCB;PRKCD;EP300,,,,,,,,,,
MAPK Signaling Pathway WP382,4/246,0.000541248177746,0.005304232141907,0,0,12.0765228037955,90.835168164006,MAX;PRKCD;ARRB1;STK4,,,,,,,,,,
PRKAA2,2/28,0.000857068831641,0.005332872730211,0,0,52.8992042440318,373.573774402989,HDAC5;EP300,,,,,,,,,,
Acetylases Inhibition in Histone Deacetylation in Cancer,2/9,8.31359912039675E-05,0.005467976697926,0,0,196.669950738916,1847.72064636806,KAT6A;EP300,,,,,,,,,,
Kruppel-like Factor 6 Signaling in Prostate Cancer,2/9,8.31359912039675E-05,0.005467976697926,0,0,196.669950738916,1847.72064636806,CDH1;EP300,,,,,,,,,,
Peripheral Tissue Microangiopathy,3/46,4.89213024824683E-05,0.005467976697926,0,0,49.6495016611296,492.786080808225,PRKCB;PRKCD;EP300,,,,,,,,,,
Hepatic Stellate Cells in non-Alcoholic Fatty Liver Disease,3/55,8.37545664890234E-05,0.005467976697926,0,0,41.0377747252747,385.24702916497,CDH1;EP300;JAK2,,,,,,,,,,
Proteins Involved in Prostate Cancer,4/138,5.90758038541216E-05,0.005467976697926,0,0,21.9292426755113,213.518218735926,CDH1;VDR;EP300;JAK2,,,,,,,,,,
Nuclear beta-catenin signaling and target gene transcription regulation,3/80,0.000255509192583,0.005605232912285,0,0,27.6790352504638,228.967959418865,TLE4;CDH1;EP300,,,,,,,,,,
CSNK1E,3/128,0.001009600079265,0.005653760443882,0,0,17.0091428571429,117.332486056501,MAX;CDH1;STK4,,,,,,,,,,
SMAD2/3 nuclear pathway,3/82,0.000274835936022,0.005674553737862,0,0,26.9755877034358,221.181913706857,MAX;VDR;EP300,,,,,,,,,,
IFNG -> ARRB1/STAT1 Signaling,2/10,0.000103819783502,0.005930705132529,0,0,172.077586206897,1578.44257716669,ARRB1;JAK2,,,,,,,,,,
PS1-E-cadherin-catenin complex, brain (mouse),1/4,0.006185985771587,0.009172323730285,0,0,221.844444444444,1128.1830239295,CDH1,,,,,,,,,
Proteins Involved in Diabetic Neuropathy,3/65,0.000137992883954,0.006306274796707,0,0,34.4014976958525,305.771122307878,VDR;PRKCB;PRKCD,,,,,,,,,,
Clear Cell Endometrial Cancer and Papillary Serous Endometrial Cancer,3/65,0.000137992883954,0.006306274796707,0,0,34.4014976958525,305.771122307878,CDH1;EP300;JAK2,,,,,,,,,,
CREB1,3/124,0.000921021306297,0.00647784985429,0,0,17.5749704840614,122.849525028698,ATF7IP;PRKCB;EP300,,,,,,,,,,
Attenuation of GPCR Signaling Homo sapiens h agpcrPathway,2/13,0.000179434089994,0.006818495419765,0,0,125.128526645768,1079.32145813929,PRKCB;ARRB1,,,,,,,,,,
Erythropoietin mediated neuroprotection through NF-kB Homo sapiens h eponfkbPathway,2/13,0.000179434089994,0.006818495419765,0,0,125.128526645768,1079.32145813929,EP300;JAK2,,,,,,,,,,
Genes with Mutations in Cancer-Associated Histone Deacetylation,2/13,0.000179434089994,0.007166549674611,0,0,125.128526645768,1079.32145813929,KAT6A;EP300,,,,,,,,,,
Protein Kinase C in Diabetic Microangiopathy,2/14,0.000209137833058,0.007166549674611,0,0,114.695402298851,971.758749818832,PRKCB;PRKCD,,,,,,,,,,
CXC Chemokine Receptor Signaling,3/75,0.000211099099823,0.007166549674611,0,0,29.608630952381,250.583258201602,PRKCB;PRKCD;JAK2,,,,,,,,,,
Mast-Cell Activation in Asthma,3/76,0.000219544191345,0.007166549674611,0,0,29.2015655577299,245.992733128358,PRKCB;PRKCD;JAK2,,,,,,,,,,
IL13/STAT6/ZEB1 Signalling Promotes Cancer Metastatic Progression,2/15,0.000241080096237,0.00734490693203,0,0,105.867374005305,881.915595886549,CDH1;JAK2,,,,,,,,,,
CDC73 Mutations Cause Hyperparathyroidism,2/16,0.000275254319786,0.007399483773074,0,0,98.3004926108374,805.849261526094,KMT2A;CTR9,,,,,,,,,,
Acute Myeloid Leukemia,3/82,0.000274835936022,0.007399483773074,0,0,26.9755877034358,221.181913706857,KMT2A;KAT6A;JAK2,,,,,,,,,,
protein citrullination Homo sapiens PWY-4921,1/5,0.007726694289036,0.007726694289036,0,0,166.375,809.093962505696,PADI4,,,,,,,,,,
Retinoic acid receptors-mediated signaling Homo sapiens 5797691b-6195-11e5-8ac5-06603eb7f303,2/28,0.000857068831641,0.007799326367933,0,0,52.8992042440318,373.573774402989,VDR;EP300,,,,,,,,,,
IL8- and CXCR1-mediated signaling events Homo sapiens f6a58ef3-6193-11e5-8ac5-06603eb7f303,2/28,0.000857068831641,0.007799326367933,0,0,52.8992042440318,373.573774402989,PRKCB;ARRB1,,,,,,,,,,
NFKBIA,3/134,0.001152309345799,0.00784313780528,0,0,16.2251908396947,109.779433918863,HDAC5;ARRB1;JAK2,,,,,,,,,,
TGF beta signaling pathway Homo sapiens h tgfbPathway,2/20,0.000434140102652,0.007957403046316,0,0,76.4406130268199,591.814176843113,CDH1;EP300,,,,,,,,,,
Control of skeletal myogenesis by HDAC and calcium/calmodulin-dependent kinase (CaMK) Homo sapiens h hdacPathway,2/21,0.000479376211312,0.007957403046316,0,0,72.4137931034483,553.460420823284,HDAC5;EP300,,,,,,,,,,
Growth Hormone Signaling Pathway Homo sapiens h ghPathway,2/22,0.000526805209193,0.007957403046316,0,0,68.7896551724138,519.271073554538,PRKCB;JAK2,,,,,,,,,,
TPO Signaling Pathway Homo sapiens h TPOPathway,2/24,0.000628216029972,0.007957403046316,0,0,62.5297805642633,461.00871434329,PRKCB;JAK2,,,,,,,,,,
CR3 Mediated Phagocytosis in Neutrophils and Macrophages,2/18,0.000350272477686,0.008003726115123,0,0,86.0043103448276,684.319027635324,PRKCB;PRKCD,,,,,,,,,,
Mast-Cell Activation via IgE Signaling,3/86,0.000316272256776,0.008003726115123,0,0,25.6703958691911,206.875336640049,PRKCB;PRKCD;JAK2,,,,,,,,,,
CC Chemokine Receptor Signaling,3/88,0.000338419029097,0.008003726115123,0,0,25.0638655462185,200.291006475676,PRKCB;PRKCD;JAK2,,,,,,,,,,
Control of Gene Expression by Vitamin D Receptor Homo sapiens h vdrPathway,2/27,0.000796617769219,0.00814215390059,0,0,55.0179310344828,392.560397324866,VDR;EP300,,,,,,,,,,
Role of ERBB2 in Signal Transduction and Oncology Homo sapiens h her2Pathway,2/28,0.000857068831641,0.00814215390059,0,0,52.8992042440318,373.573774402989,EP300;JAK2,,,,,,,,,,
Role of MEF2D in T-cell Apoptosis Homo sapiens h mef2dPathway,2/30,0.00098440836307,0.008312781732592,0,0,49.115763546798,340.05150286392,PRKCB;EP300,,,,,,,,,,
Histamine H1 receptor mediated signaling pathway Homo sapiens P04385,2/26,0.000738321015111,0.008367638171261,0,0,57.3132183908046,413.293174455873,PRKCB;PRKCD,,,,,,,,,,
PDGFR-beta pathway WP3972,2/29,0.000919667819372,0.008449448090479,0,0,50.9374201787995,356.128872274134,PRKCB;JAK2,,,,,,,,,,
Monkeypox virus ser/thr kinase,6/512,0.000116724692314,0.008500892591638,0,0,9.23146245059289,83.5972848449549,PRKCB;UIMC1;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Interferon-gamma signaling pathway,3/97,0.000450429125066,0.008574870543528,0,0,22.6538753799392,174.555128388526,PRKCD;EP300;JAK2,,,,,,,,,,
Wnt signaling pathway and pluripotency,3/98,0.000464166781558,0.008574870543528,0,0,22.4142857142857,172.035619117808,PRKCB;PRKCD;EP300,,,,,,,,,,
Bioactive Peptide Induced Signaling Pathway Homo sapiens h biopeptidesPathway,2/33,0.001191415839123,0.009054760377335,0,0,44.3559510567297,298.631448201405,PRKCB;JAK2,,,,,,,,,,
NPM1,3/144,0.001417368326926,0.009062567181255,0,0,15.0668693009119,98.8228938957741,EP300;ARRB1;PADI4,,,,,,,,,,
PRKCA,5/547,0.001416971375085,0.009062567181255,0,0,6.89291796764121,45.212258580838,VDR;PRKCB;ZMYND8;PRKCD;EP300,,,,,,,,,,
OCT2-TLE4 complex (human),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,TLE4,,,,,,,,,,
BCL6-HDAC5 complex (human),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,HDAC5,,,,,,,,,,
Vdr-Med4 complex (mouse),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,VDR,,,,,,,,,,
Cell-cell junction complex (CDH1-CTNNB1) (human),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,CDH1,,,,,,,,,,
Gata1-Gfi1b complex (mouse),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,GFI1B,,,,,,,,,,
MAD-MAX complex (human),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,MAX,,,,,,,,,,
MYC-MAX complex (human),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,MAX,,,,,,,,,,
CDH1-CKS1B complex (human),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,CDH1,,,,,,,,,,
CDH1-SKP2 complex (human),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,CDH1,,,,,,,,,,
SETDB1-containing HMTase complex (human),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,ATF7IP,,,,,,,,,,
MBD1-MCAF complex (human),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,ATF7IP,,,,,,,,,,
EGR-EP300 complex (human),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,EP300,,,,,,,,,,
SMAD3-VDR complex (mouse),1/2,0.003097625423707,0.00907488362133,0,0,665.6,3845.25070816018,VDR,,,,,,,,,,
Src1-Ep300-Crebbp complex (mouse),1/3,0.004642963713238,0.00907488362133,0,0,332.783333333333,1787.84597380293,EP300,,,,,,,,,,
ING1-p300-PCNA complex (human),1/3,0.004642963713238,0.00907488362133,0,0,332.783333333333,1787.84597380293,EP300,,,,,,,,,,
p300-CBP-p270 complex (human),1/3,0.004642963713238,0.00907488362133,0,0,332.783333333333,1787.84597380293,EP300,,,,,,,,,,
p300-MDM2-p53 protein complex (human),1/3,0.004642963713238,0.00907488362133,0,0,332.783333333333,1787.84597380293,EP300,,,,,,,,,,
MBD1-MCAF1-SETDB1 complex (human),1/3,0.004642963713238,0.00907488362133,0,0,332.783333333333,1787.84597380293,ATF7IP,,,,,,,,,,
TCF4-CTNNB1-EP300 complex (human),1/3,0.004642963713238,0.00907488362133,0,0,332.783333333333,1787.84597380293,EP300,,,,,,,,,,
PIAS3-SMAD3-P300 complex (human),1/3,0.004642963713238,0.00907488362133,0,0,332.783333333333,1787.84597380293,EP300,,,,,,,,,,
Polycystin-1-E-cadherin-beta-catenin complex (human),1/3,0.004642963713238,0.00907488362133,0,0,332.783333333333,1787.84597380293,CDH1,,,,,,,,,,
Polycystin-1-E-cadherin-beta-catenin-Flotillin-2 complex (human),1/4,0.006185985771587,0.009172323730285,0,0,221.844444444444,1128.1830239295,CDH1,,,,,,,,,,
Multisubunit ACTR coactivator complex (human),1/4,0.006185985771587,0.009172323730285,0,0,221.844444444444,1128.1830239295,EP300,,,,,,,,,,
Smad1-Notch1-p300-Pcaf complex (mouse),1/4,0.006185985771587,0.009172323730285,0,0,221.844444444444,1128.1830239295,EP300,,,,,,,,,,
BRCA1 A complex (human),1/4,0.006185985771587,0.009172323730285,0,0,221.844444444444,1128.1830239295,UIMC1,,,,,,,,,,
BRCA1 C complex (human),1/4,0.006185985771587,0.009172323730285,0,0,221.844444444444,1128.1830239295,UIMC1,,,,,,,,,,
SMAD3-HEF1-APC10-CDH1 complex (human),1/4,0.006185985771587,0.009172323730285,0,0,221.844444444444,1128.1830239295,CDH1,,,,,,,,,,
PPP1CA,2/46,0.00230636321186,0.009225452847442,0,0,31.230407523511,189.63363791907,PRKCB;STK4,,,,,,,,,,
Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,2/32,0.001120288708809,0.009687202364409,0,0,45.8367816091954,311.422833847125,HDAC5;EP300,,,,,,,,,,
CHUK,3/157,0.001815299607968,0.010352113980576,0,0,13.7859461966605,87.0100649259055,PRKCB;EP300;ARRB1,,,,,,,,,,
CTNNB1,4/337,0.001739485586427,0.010352113980576,0,0,8.73584695806918,55.5090204069877,CHD9;CDH1;PRKCB;EP300,,,,,,,,,,
PRKCB,4/338,0.001758420304396,0.010352113980576,0,0,8.70924817032602,55.2457173009304,PRKCB;ZMYND8;UIMC1;STK4,,,,,,,,,,
ACTB,4/339,0.001777498353743,0.010352113980576,0,0,8.68280818131564,54.9843023827599,ATF7IP;PRKCB;PRKCD;ARRB1,,,,,,,,,,
Paf complex (human),1/5,0.007726694289036,0.010382745450892,0,0,166.375,809.093962505696,CTR9,,,,,,,,,,
TCF4-CTNNB1-SUMO1-EP300-HADAC6 complex (human),1/5,0.007726694289036,0.010382745450892,0,0,166.375,809.093962505696,EP300,,,,,,,,,,
Proteins Involved in Colorectal Neoplasms,3/99,0.000478170911655,0.010405909839358,0,0,22.1796875,169.575739727627,CDH1;VDR;PRKCB,,,,,,,,,,
IL8- and CXCR2-mediated signaling events Homo sapiens fe78e284-6193-11e5-8ac5-06603eb7f303,2/34,0.001264659182565,0.010462180510313,0,0,42.9676724137931,286.721241951116,PRKCB;ARRB1,,,,,,,,,,
HDAC3,3/164,0.00205570643383,0.010764025606647,0,0,13.1818988464951,81.5581972987139,HDAC5;ZBTB16;EP300,,,,,,,,,,
ACTA1,3/165,0.002091587914088,0.010764025606647,0,0,13.0998677248677,80.8239795997835,PRKCB;PRKCD;ARRB1,,,,,,,,,,
POLR2A,3/165,0.002091587914088,0.010764025606647,0,0,13.0998677248677,80.8239795997835,ATF7IP;VDR;EP300,,,,,,,,,,
ABL1,4/351,0.002017824117805,0.010764025606647,0,0,8.3774148788558,51.9880210588536,PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Oxytocin receptor mediated signaling pathway Homo sapiens P04391,2/39,0.001662398983033,0.01087691923974,0,0,37.1519105312209,237.753411791154,PRKCB;PRKCD,,,,,,,,,,
Thyrotropin-releasing hormone receptor signaling pathway Homo sapiens P04394,2/41,0.001836088840949,0.01087691923974,0,0,35.2431476569408,222.035974820145,PRKCB;PRKCD,,,,,,,,,,
Muscarinic acetylcholine receptor 1 and 3 signaling pathway Homo sapiens P00042,2/42,0.001926036125594,0.01087691923974,0,0,34.3603448275862,214.830881903165,PRKCB;PRKCD,,,,,,,,,,
5HT2 type receptor mediated signaling pathway Homo sapiens P04374,2/46,0.00230636321186,0.01087691923974,0,0,31.230407523511,189.63363791907,PRKCB;PRKCD,,,,,,,,,,
VEGF signaling pathway Homo sapiens P00056,2/54,0.003164322327735,0.01087691923974,0,0,26.4151193633952,152.040576203559,PRKCB;PRKCD,,,,,,,,,,
Alzheimer disease-amyloid secretase pathway Homo sapiens P00003,2/56,0.00339879969708,0.01087691923974,0,0,25.4342273307791,144.576616218793,PRKCB;PRKCD,,,,,,,,,,
B cell activation Homo sapiens P00010,2/57,0.003519003283445,0.01087691923974,0,0,24.9705329153605,141.072960611524,PRKCB;PRKCD,,,,,,,,,,
Inflammation mediated by chemokine and cytokine signaling pathway Homo sapiens P00031,3/188,0.003027176070124,0.01087691923974,0,0,11.4579150579151,66.457340538804,PRKCB;ARRB1;JAK2,,,,,,,,,,
Human gammaherpesvirus 8 ORF72,5/337,0.000156269291087,0.011064733971658,0,0,11.3745366079703,99.6856404991918,PRKCB;PRKCD;EP300;TLK1;JAK2,,,,,,,,,,
Proteins Involved in Obesity,3/106,0.000583841527305,0.011600677303403,0,0,20.6650485436893,153.869491681428,VDR;PRKCD;EP300,,,,,,,,,,
Endometrial Cancer,3/106,0.000583841527305,0.011600677303403,0,0,20.6650485436893,153.869491681428,CDH1;EP300;JAK2,,,,,,,,,,
TPO signaling pathway,2/25,0.000682184965402,0.011650534874822,0,0,59.808095952024,436.013562840355,PRKCB;JAK2,,,,,,,,,,
CARM1 and regulation of the estrogen receptor,2/26,0.000738321015111,0.011650534874822,0,0,57.3132183908046,413.293174455873,HDAC5;EP300,,,,,,,,,,
RORA activates circadian expression,2/27,0.000796617769219,0.011650534874822,0,0,55.0179310344828,392.560397324866,CHD9;EP300,,,,,,,,,,
Control of gene expression by vitamin D receptor,2/27,0.000796617769219,0.011650534874822,0,0,55.0179310344828,392.560397324866,VDR;EP300,,,,,,,,,,
Hemostasis pathway,5/468,0.000705784815059,0.011650534874822,0,0,8.10184416015949,58.7886029031121,PRKCB;PRKCD;EP300;ARRB1;JAK2,,,,,,,,,,
TLE-Histone H3 complex (human),1/6,0.009265092249714,0.011717616668757,0,0,133.093333333333,623.076634648791,TLE4,,,,,,,,,,
HES1 promoter corepressor complex (human),1/6,0.009265092249714,0.011717616668757,0,0,133.093333333333,623.076634648791,EP300,,,,,,,,,,
H2AFX,3/172,0.002353733721103,0.011741260758222,0,0,12.552831783601,75.9666298000289,UIMC1;ARRB1;STK4,,,,,,,,,,
PRKCD,3/173,0.002392768780112,0.011741260758222,0,0,12.4783613445378,75.3107053610453,HDAC5;PRKCD;EP300,,,,,,,,,,
Proteins Involved in Arterial Hypertension,4/255,0.000619406497213,0.011794532051102,0,0,11.6381879887856,85.968371171426,VDR;PRKCB;PRKCD;JAK2,,,,,,,,,,
ERBB2,3/175,0.002472042679857,0.01185456830568,0,0,12.3320182724252,74.0255352521753,CDH1;PRKCB;JAK2,,,,,,,,,,
PRKX human kinase ARCHS4 coexpression,4/299,0.001120462674854,0.012111667961518,0,0,9.88022598870056,67.1263895054303,KAT6A;EP300;STK4;JARID2,,,,,,,,,,
CDK13 human kinase ARCHS4 coexpression,4/299,0.001120462674854,0.012111667961518,0,0,9.88022598870056,67.1263895054303,KMT2A;KAT6A;EP300;STK4,,,,,,,,,,
PRPF4B human kinase ARCHS4 coexpression,4/299,0.001120462674854,0.012111667961518,0,0,9.88022598870056,67.1263895054303,KMT2A;KAT6A;EP300;NAP1L1,,,,,,,,,,
MAP3K1 human kinase ARCHS4 coexpression,4/299,0.001120462674854,0.012111667961518,0,0,9.88022598870056,67.1263895054303,PRKCB;KAT6A;STK4;JAK2,,,,,,,,,,
MAP3K2 human kinase ARCHS4 coexpression,4/299,0.001120462674854,0.012111667961518,0,0,9.88022598870056,67.1263895054303,KAT6A;TET2;STK4;JAK2,,,,,,,,,,
MAP3K5 human kinase ARCHS4 coexpression,4/299,0.001120462674854,0.012111667961518,0,0,9.88022598870056,67.1263895054303,PRKCB;PRKCD;STK4;JAK2,,,,,,,,,,
IGF1R human kinase ARCHS4 coexpression,4/299,0.001120462674854,0.012111667961518,0,0,9.88022598870056,67.1263895054303,KMT2A;CDH1;ZMYND8;EP300,,,,,,,,,,
BMP2K human kinase ARCHS4 coexpression,4/299,0.001120462674854,0.012111667961518,0,0,9.88022598870056,67.1263895054303,PRKCB;USP12;EP300;JAK2,,,,,,,,,,
Fc gamma R-mediated phagocytosis,3/97,0.000450429125066,0.012154901046561,0,0,22.6538753799392,174.555128388526,PRKCB;PRKCD;ACTR3B,,,,,,,,,,
AGE-RAGE signaling pathway in diabetic complications,3/100,0.00049244367983,0.012154901046561,0,0,21.9499263622975,167.173502753114,PRKCB;PRKCD;JAK2,,,,,,,,,,
Insulin resistance,3/108,0.000616552951637,0.012154901046561,0,0,20.269387755102,149.818470554006,PRKAB2;PRKCB;PRKCD,,,,,,,,,,
Chemokine signaling pathway,4/192,0.000211428993662,0.012154901046561,0,0,15.5878644602049,131.898606611617,PRKCB;PRKCD;ARRB1;JAK2,,,,,,,,,,
Chemical carcinogenesis,4/239,0.000485529353556,0.012154901046561,0,0,12.4406619385343,94.9256196665228,VDR;PRKCB;ARRB1;JAK2,,,,,,,,,,
Type II interferon signaling (IFNG) WP619,2/37,0.001497023535475,0.012163589844014,0,0,39.2788177339901,255.480289245992,PRKCD;JAK2,,,,,,,,,,
Calcium Regulation in the Cardiac Cell WP536,3/150,0.001593345985451,0.012163589844014,0,0,14.4475218658892,93.0697667740885,PRKCB;PRKCD;ARRB1,,,,,,,,,,
Hepatitis B infection WP4666,3/152,0.001654910182859,0.012163589844014,0,0,14.2521572387344,91.2709366959546,PRKCB;EP300;JAK2,,,,,,,,,,
Vitamin D-sensitive calcium signaling in depression WP4698,2/41,0.001836088840949,0.012268411800883,0,0,35.2431476569408,222.035974820145,KDM3A;VDR,,,,,,,,,,
Myometrial relaxation and contraction pathways WP289,3/156,0.001782474829071,0.012268411800883,0,0,13.8767507002801,87.836397810449,PRKCB;PRKCD;ARRB1,,,,,,,,,,
IL-6 signaling pathway WP364,2/43,0.002018043381393,0.012360515711034,0,0,33.5206055508831,208.016370172042,PRKCD;JAK2,,,,,,,,,,
EGF/EGFR signaling pathway WP437,3/162,0.001985104389397,0.012360515711034,0,0,13.3490566037736,83.0589485340456,PRKCB;PRKCD;JAK2,,,,,,,,,,
NK-3-Groucho complex (human),1/7,0.010801182772693,0.012901412756272,0,0,110.905555555556,502.191405614873,TLE4,,,,,,,,,,
p300-CBP-p270-SWI/SNF complex (human),1/7,0.010801182772693,0.012901412756272,0,0,110.905555555556,502.191405614873,EP300,,,,,,,,,,
SIN3A,3/183,0.002805396212539,0.012987070443254,0,0,11.7791666666667,69.2168628213039,HDAC5;VDR;ZBTB16,,,,,,,,,,
NFKB2,3/184,0.002848917340334,0.012987070443254,0,0,11.7134964483031,68.6506501816324,HDAC5;PRKCB;EP300,,,,,,,,,,
EEF1A1,3/185,0.002892854553711,0.012987070443254,0,0,11.6485478806907,68.0917209384981,PRKCB;ZBTB16;PRKCD,,,,,,,,,,
Retinoic acid receptor-mediated signaling,2/30,0.00098440836307,0.013289512901446,0,0,49.115763546798,340.05150286392,VDR;EP300,,,,,,,,,,
MicroRNAs in muscle cell differentiation,2/30,0.00098440836307,0.013289512901446,0,0,49.115763546798,340.05150286392,PRKCB;PRKCD,,,,,,,,,,
HNRNPK,3/188,0.003027176070124,0.013306961474922,0,0,11.4579150579151,66.457340538804,GFI1B;PRKCD;ARRB1,,,,,,,,,,
CDK1,5/659,0.003193030779933,0.013749581521751,0,0,5.67954598917902,32.6391281382744,TLE4;PRKCB;ZBTB16;CTR9;UIMC1,,,,,,,,,,
Tertiary Hypothyroidism,2/28,0.000857068831641,0.014009606448431,0,0,52.8992042440318,373.573774402989,PRKCB;JAK2,,,,,,,,,,
Histone Methylation,2/28,0.000857068831641,0.014009606448431,0,0,52.8992042440318,373.573774402989,KDM3A;GFI1B,,,,,,,,,,
Central Hypothyroidism,2/28,0.000857068831641,0.014009606448431,0,0,52.8992042440318,373.573774402989,PRKCB;JAK2,,,,,,,,,,
Eat me Signal: Apoptotic Cell Induces Phagocytosis,2/29,0.000919667819372,0.014009606448431,0,0,50.9374201787995,356.128872274134,PRKCB;PRKCD,,,,,,,,,,
IL6 Promotes Inflammation in Muscular Dystrophies,2/29,0.000919667819372,0.014009606448431,0,0,50.9374201787995,356.128872274134,PRKCD;JAK2,,,,,,,,,,
Prostate Cancer,3/123,0.000899679605515,0.014009606448431,0,0,17.7223214285714,124.295002489485,VDR;EP300;JAK2,,,,,,,,,,
CSNK1E,3/195,0.003355402117059,0.014011354713367,0,0,11.0362723214286,62.8756703335021,MAX;CDH1;STK4,,,,,,,,,,
LYN,3/197,0.003453035284811,0.014011354713367,0,0,10.9213917525773,61.9079270827462,PRKCB;PRKCD;JAK2,,,,,,,,,,
MAPK1,4/406,0.003412087668972,0.014011354713367,0,0,7.21098212640501,40.9614860895001,PRKCD;EP300;ARRB1;JAK2,,,,,,,,,,
CDK2,5/675,0.003538974460061,0.014089124737222,0,0,5.53932261768083,31.2634842602668,PRKCB;ZMYND8;ZBTB16;EP300;TLK1,,,,,,,,,,
Energy Metabolism WP1541,2/47,0.002406548654002,0.014150506085532,0,0,30.5348659003831,184.111856472173,PRKAB2;EP300,,,,,,,,,,
Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway,2/31,0.001051284107162,0.014191770784633,0,0,47.4197384066587,325.192374511661,CDH1;EP300,,,,,,,,,,
Vitamine D Deficite and Dentin Formation,2/31,0.001051284107162,0.014191770784633,0,0,47.4197384066587,325.192374511661,VDR;PRKCD,,,,,,,,,,
Hippo/YAP1 Signaling,2/31,0.001051284107162,0.014191770784633,0,0,47.4197384066587,325.192374511661,CDH1;STK4,,,,,,,,,,
Proteins Involved in Hepatocellular Carcinoma,3/130,0.001055842903014,0.014191770784633,0,0,16.7395950506187,114.723406391509,EP300;STK4;JAK2,,,,,,,,,,
Apoptosis Block in Acute Myeloid Leukemia Cell,2/32,0.001120288708809,0.014627769712166,0,0,45.8367816091954,311.422833847125,KMT2A;JAK2,,,,,,,,,,
PTPRT,1/4,0.006185985771587,0.01484636585181,0,0,221.844444444444,1128.1830239295,CDH1,,,,,,,,,,
PTPN23,1/4,0.006185985771587,0.01484636585181,0,0,221.844444444444,1128.1830239295,CDH1,,,,,,,,,,
FoxO signaling pathway,3/131,0.001079459168308,0.014896536522649,0,0,16.6079799107143,113.454012338978,PRKAB2;EP300;STK4,,,,,,,,,,
MAPK signaling pathway,4/294,0.001052677366517,0.014896536522649,0,0,10.05312899106,68.9284594700132,MAX;PRKCB;ARRB1;STK4,,,,,,,,,,
up Rapamycin vs Ctrl Exp1 MEFs (Mouse) [21659605],6/837,0.001583365954664,0.015305870895088,0,0,5.5272202166065,35.6406343723899,ATF7IP;CHD9;ZMYND8;UIMC1;NAP1L1;STK4,,,,,,,,,,
Apelin signaling pathway,3/137,0.001228199575405,0.015408321945992,0,0,15.8595415778252,106.293913796711,HDAC5;PRKAB2;CDH1,,,,,,,,,,
PRKAA1,2/53,0.003050060586094,0.015527581165571,0,0,26.9344151453685,156.020126831303,HDAC5;EP300,,,,,,,,,,
Proteins Involved in Acute Myeloid Leukemia,2/34,0.001264659182565,0.015620249903577,0,0,42.9676724137931,286.721241951116,KMT2A;JAK2,,,,,,,,,,
TSLP Signaling in Bronchial Epithelial Cell in Asthma,2/34,0.001264659182565,0.015620249903577,0,0,42.9676724137931,286.721241951116,VDR;JAK2,,,,,,,,,,
NR3C1,3/209,0.004075533969149,0.015924771620192,0,0,10.2789528432732,56.562543791189,CHD9;ZBTB16;EP300,,,,,,,,,,
Signaling pathways regulating pluripotency of stem cells,3/143,0.001389292092197,0.01597685906026,0,0,15.1752551020408,99.8374106886124,KAT6A;JARID2;JAK2,,,,,,,,,,
JUN,3/211,0.004185489136735,0.016046190346721,0,0,10.1790865384615,55.7420185041041,VDR;EP300;ARRB1,,,,,,,,,,
YWHAE,3/215,0.004410801137961,0.016046190346721,0,0,9.98500673854447,54.1556704845599,HDAC5;TLK1;ARRB1,,,,,,,,,,
IGF1R,3/215,0.004410801137961,0.016046190346721,0,0,9.98500673854447,54.1556704845599,PRKCD;ARRB1;JAK2,,,,,,,,,,
FYN,4/433,0.004291746927771,0.016046190346721,0,0,6.74782008115341,36.7827817111737,MAX;CDH1;PRKCD;JAK2,,,,,,,,,,
NOTCH1 Signaling in Breast Cancer,2/35,0.001340012436764,0.016115412726343,0,0,41.6635318704284,275.607445745744,CDH1;EP300,,,,,,,,,,
PPP2CA,2/88,0.008192491185328,0.016384982370656,0,0,15.9446672012831,76.6067475606087,PRKCB;STK4,,,,,,,,,,
Human immunodeficiency virus 2 vif protein,2/15,0.000241080096237,0.016608463927268,0,0,105.867374005305,881.915595886549,ZBTB16;EP300,,,,,,,,,,
Estrogen Effects on Pregnancy Gingivitis,2/36,0.001417469313043,0.016609832719501,0,0,40.4361054766734,265.215651285486,CDH1;EP300,,,,,,,,,,
MEF2D role in T cell apoptosis,2/35,0.001340012436764,0.016798013046574,0,0,41.6635318704284,275.607445745744,PRKCB;EP300,,,,,,,,,,
EGF/EGFR signaling pathway,3/141,0.001334198664258,0.016798013046574,0,0,15.3967391304348,101.917550970589,PRKCB;PRKCD;JAK2,,,,,,,,,,
SMAD4,3/221,0.004762405649497,0.016959515920836,0,0,9.70724115334207,51.9046412575276,ATF7IP;MAX;EP300,,,,,,,,,,
ATM,3/222,0.004822611162323,0.016959515920836,0,0,9.66242661448141,51.5436327362984,KDM3A;UIMC1;EP300,,,,,,,,,,
ATR,2/58,0.003641175466029,0.016992152174803,0,0,24.5233990147783,137.70988958886,KMT2A;UIMC1,,,,,,,,,,
Endothelin signaling pathway Homo sapiens P00019,2/75,0.006013544320434,0.017038375574564,0,0,18.796410014171,96.1199719235846,PRKCB;PRKCD,,,,,,,,,,
TERT Activation in Cancer,2/37,0.001497023535475,0.017103493892797,0,0,39.2788177339901,255.480289245992,MAX;EP300,,,,,,,,,,
IL6-mediated signaling events Homo sapiens e684d5d2-6193-11e5-8ac5-06603eb7f303,2/46,0.00230636321186,0.017489921023275,0,0,31.230407523511,189.63363791907,PRKCD;JAK2,,,,,,,,,,
Notch-mediated HES/HEY network Homo sapiens 8ee56389-6194-11e5-8ac5-06603eb7f303,2/48,0.0025087632834,0.017561342983803,0,0,29.8695652173913,178.857921930788,EP300;JAK2,,,,,,,,,,
IL-4 signaling pathway WP395,2/54,0.003164322327735,0.017890591622196,0,0,26.4151193633952,152.040576203559,EP300;JAK2,,,,,,,,,,
TRPM4/6/7/8 Signaling in Arterial Hypertension (Hypothesis),2/39,0.001662398983033,0.01808848417253,0,0,37.1519105312209,237.753411791154,PRKCD;JAK2,,,,,,,,,,
Podocyte Dysfunction in Diabetic Nephropathy,2/39,0.001662398983033,0.01808848417253,0,0,37.1519105312209,237.753411791154,PRKCB;JAK2,,,,,,,,,,
Vaccinia virus Ankara serine/threonine-protein kinase-like,3/82,0.000274835936022,0.018435705287356,0,0,26.9755877034358,221.181913706857,PRKCD;EP300;JAK2,,,,,,,,,,
BMAL1-CLOCK/NPAS2 activates circadian expression,2/38,0.001578668841777,0.018470425448787,0,0,38.1858237547893,246.343366349648,CHD9;EP300,,,,,,,,,,
Calcium regulation in the cardiac cell,3/149,0.001563112714029,0.018470425448787,0,0,14.5472113502935,93.990639813285,PRKCB;PRKCD;ARRB1,,,,,,,,,,
Proteins Involved in T-Cell Acute Lymphoblastic Leukemia,2/40,0.001748207723605,0.018579789062494,0,0,36.1724137931034,229.664593734864,KMT2A;JAK2,,,,,,,,,,
HSP90AA1,3/231,0.005385343092329,0.01862799004068,0,0,9.27678571428571,48.4626174451952,CDH1;PRKCD;ARRB1,,,,,,,,,,
down 3min cross-link ZAP-70 null vs reconstituted Jurkat (Human) [19605366],2/46,0.00230636321186,0.018944257127568,0,0,31.230407523511,189.63363791907,PRKCD;STK4,,,,,,,,,,
down 2min cross-link ZAP-70 null vs reconstituted Jurkat (Human) [19605366],2/49,0.002613000983113,0.018944257127568,0,0,29.2325752017608,173.853605814568,PRKCD;STK4,,,,,,,,,,
EGFR,4/467,0.005603815819451,0.019071050611358,0,0,6.24142068634509,32.3574441807008,CDH1;PRKCB;PRKCD;JAK2,,,,,,,,,,
NK-3-Groucho-HIPK2-SIN3A-RbpA48-HDAC1 complex (human),1/11,0.016922534733464,0.019149184040499,0,0,66.53,271.383130357804,TLE4,,,,,,,,,,
PAC1 receptor pathway,2/40,0.001748207723605,0.01919558777782,0,0,36.1724137931034,229.664593734864,PRKCB;PRKCD,,,,,,,,,,
Myometrial relaxation and contraction pathways,3/155,0.001750025096553,0.01919558777782,0,0,13.96875,88.6753731927209,PRKCB;PRKCD;ARRB1,,,,,,,,,,
Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa Homo sapiens h pparaPathway,2/52,0.002937791521612,0.019317050378597,0,0,27.4744827586207,160.178903986919,PRKCB;EP300,,,,,,,,,,
Keratinocyte Differentiation Homo sapiens h keratinocytePathway,2/53,0.003050060586094,0.019317050378597,0,0,26.9344151453685,156.020126831303,PRKCB;PRKCD,,,,,,,,,,
Bioactive peptide-induced signaling pathway,2/41,0.001836088840949,0.019529308580998,0,0,35.2431476569408,222.035974820145,PRKCB;JAK2,,,,,,,,,,
Regulation of TP53 Activity through Acetylation Homo sapiens R-HSA-6804758,2/23,0.000576420632299,0.019545029952275,0,0,65.5106732348112,488.622683076179,KAT6A;EP300,,,,,,,,,,
VEGFR2 mediated cell proliferation Homo sapiens R-HSA-5218921,4/248,0.000557970894353,0.019545029952275,0,0,11.976320582878,89.7170577526801,PRKCB;PRKCD;ARRB1;JAK2,,,,,,,,,,
CAMK1D,1/3,0.004642963713238,0.020000459072412,0,0,332.783333333333,1787.84597380293,EP300,,,,,,,,,,
down 10min PPase inhibitors vs ctrl Hepa1-6 (Mouse) [18846507],6/958,0.003127079202923,0.020152288196618,0,0,4.79420168067227,27.6513054755711,TLE4;ATF7IP;ZMYND8;CTR9;PRKCD;ARRB1,,,,,,,,,,
Growth hormone receptor signaling,2/43,0.002018043381393,0.020238092196258,0,0,33.5206055508831,208.016370172042,PRKCB;JAK2,,,,,,,,,,
PI3K class IB pathway in neutrophils,2/43,0.002018043381393,0.020238092196258,0,0,33.5206055508831,208.016370172042,PRKCB;PRKCD,,,,,,,,,,
E2F-6 complex (human),1/12,0.018447136470887,0.020339150467902,0,0,60.4787878787879,241.482493848957,MAX,,,,,,,,,,
RORA activates gene expression Homo sapiens R-HSA-1368082,2/27,0.000796617769219,0.020712061999684,0,0,55.0179310344828,392.560397324866,CHD9;EP300,,,,,,,,,,
Epigenetic regulation of gene expression Homo sapiens R-HSA-212165,3/115,0.000740210641646,0.020712061999684,0,0,18.9958545918367,136.933056977761,TET2;EP300;JARID2,,,,,,,,,,
PTPRC,1/9,0.01386645428907,0.020799681433605,0,0,83.1708333333333,355.828338741317,JAK2,,,,,,,,,,
CDC14B,1/9,0.01386645428907,0.020799681433605,0,0,83.1708333333333,355.828338741317,CDH1,,,,,,,,,,
Hepatitis B,3/162,0.001985104389397,0.020974604105939,0,0,13.3490566037736,83.0589485340456,PRKCB;EP300;JAK2,,,,,,,,,,
Wnt signaling pathway,3/166,0.002127858387559,0.020974604105939,0,0,13.0188431200701,80.1002452601845,TLE4;PRKCB;EP300,,,,,,,,,,
Thromboxane A2 receptor signaling Homo sapiens 27d5800d-6196-11e5-8ac5-06603eb7f303,2/56,0.00339879969708,0.021348619919567,0,0,25.4342273307791,144.576616218793,PRKCB;PRKCD,,,,,,,,,,
p53 pathway Homo sapiens a0de862d-6194-11e5-8ac5-06603eb7f303,2/57,0.003519003283445,0.021348619919567,0,0,24.9705329153605,141.072960611524,PRKCD;EP300,,,,,,,,,,
HES1 promoter-Notch enhancer complex (human),1/13,0.019969450260865,0.02146715903043,0,0,55.4361111111111,216.952084672946,EP300,,,,,,,,,,
G alpha (z) signaling events,2/45,0.00220821308772,0.021530077605273,0,0,31.9582999198075,195.443272911183,PRKCB;PRKCD,,,,,,,,,,
Influenza A,3/172,0.002353733721103,0.021654350234147,0,0,12.552831783601,75.9666298000289,PRKCB;EP300;JAK2,,,,,,,,,,
Notch Signaling Pathway Netpath WP61,2/61,0.004019443767471,0.021883638289565,0,0,23.2729398012858,128.387773216608,EP300;JAK2,,,,,,,,,,
WINAC complex (human),1/14,0.021489479385557,0.022001133656641,0,0,51.1692307692308,196.499660131609,VDR,,,,,,,,,,
DRIP complex (human),1/14,0.021489479385557,0.022001133656641,0,0,51.1692307692308,196.499660131609,VDR,,,,,,,,,,
VEGFA-VEGFR2 Signaling Pathway WP3888,4/432,0.004256684227567,0.022347592194726,0,0,6.76393215645552,36.926096542674,HDAC5;PRKCB;PRKCD;NAP1L1,,,,,,,,,,
Proteins Involved in Dilated Cardiomyopathy,3/167,0.002164519358696,0.02248148515737,0,0,12.9388066202091,79.3867848496311,CDH1;PRKCD;STK4,,,,,,,,,,
HES/HEY pathway,2/48,0.0025087632834,0.022578869550603,0,0,29.8695652173913,178.857921930788,EP300;JAK2,,,,,,,,,,
Energy metabolism,2/48,0.0025087632834,0.022578869550603,0,0,29.8695652173913,178.857921930788,PRKAB2;EP300,,,,,,,,,,
Tuberculosis,3/180,0.002677315818224,0.023091848932185,0,0,11.9806295399516,70.9605564774126,VDR;EP300;JAK2,,,,,,,,,,
down 5min cross-link ZAP-70 null vs reconstituted Jurkat (Human) [19605366],2/61,0.004019443767471,0.023312773851332,0,0,23.2729398012858,128.387773216608,PRKCD;STK4,,,,,,,,,,
Endocrine and other factor-regulated calcium reabsorption,2/53,0.003050060586094,0.023330548556566,0,0,26.9344151453685,156.020126831303,VDR;PRKCB,,,,,,,,,,
Neutrophil extracellular trap formation,3/189,0.003072790945414,0.023330548556566,0,0,11.3957373271889,65.9262666322136,HDAC5;PRKCB;PADI4,,,,,,,,,,
Transcriptional misregulation in cancer,3/192,0.003212176975179,0.023330548556566,0,0,11.2131519274376,64.3725341954727,KMT2A;MAX;ZBTB16,,,,,,,,,,
YWHAZ,4/500,0.007112686652485,0.023821855296417,0,0,5.8163082437276,28.7667349133759,HDAC5;PRKCB;PRKCD;ARRB1,,,,,,,,,,
Type II interferon signaling (interferon-gamma),2/50,0.00271925564825,0.023861468313398,0,0,28.6221264367816,169.082266561275,PRKCD;JAK2,,,,,,,,,,
HDGFRP2,2/13,0.000179434089994,0.023864733969176,0,0,125.128526645768,1079.32145813929,MBD5;ARRB1,,,,,,,,,,
Validated targets of C-MYC transcriptional repression Homo sapiens 6bbdafa6-6196-11e5-8ac5-06603eb7f303,2/63,0.004281356167812,0.024350213204429,0,0,22.5076314301865,122.745040697201,MAX;EP300,,,,,,,,,,
Human betacoronavirus 2c Jordan-N3/2012 ORF1a protein (gene: ORF1ab),3/91,0.000373476562195,0.024410045052173,0,0,24.205762987013,191.047743703822,APOBEC3C;UIMC1;EP300,,,,,,,,,,
Human betacoronavirus 2c EMC/2012 ORF1a (gene: orf1ab),3/92,0.000385661436447,0.024576275037566,0,0,23.9325842696629,188.123291579814,APOBEC3C;UIMC1;EP300,,,,,,,,,,
CDC14A,1/12,0.018447136470887,0.024596181961183,0,0,60.4787878787879,241.482493848957,CDH1,,,,,,,,,,
Vitamin D metabolism and pathway Homo sapiens P04396,1/8,0.012334969042911,0.02469142480556,0,0,95.0571428571429,417.80627965005,VDR,,,,,,,,,,
FGF signaling pathway Homo sapiens P00021,2/99,0.01027285049438,0.02469142480556,0,0,14.128688233203,64.6846773322161,PRKCB;PRKCD,,,,,,,,,,
Apoptosis signaling pathway Homo sapiens P00006,2/102,0.010876814513193,0.02469142480556,0,0,13.7027586206897,61.9518415990021,PRKCB;PRKCD,,,,,,,,,,
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway Homo sapiens P00027,2/106,0.011706035120323,0.02469142480556,0,0,13.1730769230769,58.5892454293203,PRKCB;PRKCD,,,,,,,,,,
EGF receptor signaling pathway Homo sapiens P00018,2/109,0.01234571240278,0.02469142480556,0,0,12.8018047051241,56.2568452406774,PRKCB;PRKCD,,,,,,,,,,
CAMK1G,1/4,0.006185985771587,0.024743943086349,0,0,221.844444444444,1128.1830239295,EP300,,,,,,,,,,
Negative Acute Phase Proteins Synthesis,2/48,0.0025087632834,0.024877946860054,0,0,29.8695652173913,178.857921930788,VDR;JAK2,,,,,,,,,,
Insulin Resistance in Hepatocytes,2/49,0.002613000983113,0.024877946860054,0,0,29.2325752017608,173.853605814568,PRKCD;JAK2,,,,,,,,,,
Mesangial Cell Dysfunction in Diabetic Nephropathy,2/49,0.002613000983113,0.024877946860054,0,0,29.2325752017608,173.853605814568,PRKCB;PRKCD,,,,,,,,,,
Proteins Involved in Diabetic Nephropathy,3/175,0.002472042679857,0.024877946860054,0,0,12.3320182724252,74.0255352521753,VDR;PRKCB;JAK2,,,,,,,,,,
Apoptotic execution  phase,2/52,0.002937791521612,0.024897006179513,0,0,27.4744827586207,160.178903986919,CDH1;PRKCD,,,,,,,,,,
Thrombin signaling through protease-activated receptors,2/53,0.003050060586094,0.024897006179513,0,0,26.9344151453685,156.020126831303,PRKCB;ARRB1,,,,,,,,,,
PI3K pathway,2/53,0.003050060586094,0.024897006179513,0,0,26.9344151453685,156.020126831303,PRKCB;PRKCD,,,,,,,,,,
PRKCB,3/250,0.006699279718042,0.02501064428069,0,0,8.55494505494505,42.8239612346146,VDR;PRKCB;STK4,,,,,,,,,,
Betacoronavirus England 1 ORF1a protein (gene: orf1ab),3/95,0.000423744521726,0.025119181066989,0,0,23.1486801242236,179.781442348459,APOBEC3C;UIMC1;EP300,,,,,,,,,,
Human betacoronavirus 2c England-Qatar/2012 ORF1a,3/95,0.000423744521726,0.025119181066989,0,0,23.1486801242236,179.781442348459,APOBEC3C;UIMC1;EP300,,,,,,,,,,
Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),6/650,0.000423406074476,0.025119181066989,0,0,7.20186335403727,55.9381607418531,KMT2A;PRKCB;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
Non-small cell lung cancer,2/54,0.003164322327735,0.025242662205344,0,0,26.4151193633952,152.040576203559,PRKCB;STK4,,,,,,,,,,
Neutrophil Activation via FCGR3B,2/50,0.00271925564825,0.025336807499435,0,0,28.6221264367816,169.082266561275,PRKCB;PRKCD,,,,,,,,,,
ESR1 Signaling in Breast Cancer,2/51,0.002827521187027,0.025336807499435,0,0,28.036593947924,164.528682262451,EP300;JAK2,,,,,,,,,,
Myocardial Remodeling,2/51,0.002827521187027,0.025336807499435,0,0,28.036593947924,164.528682262451,PRKCD;ARRB1,,,,,,,,,,
YWHAB,5/812,0.007697603424127,0.025378036288918,0,0,4.56629491945477,22.223455269474,ATF7IP;HDAC5;PRKCB;PRKCD;ARRB1,,,,,,,,,,
BMPR2,1/5,0.007726694289036,0.025452640010942,0,0,166.375,809.093962505696,PRKCB,,,,,,,,,,
SRC,3/259,0.007382740639194,0.025452640010942,0,0,8.25041852678571,40.4980897640177,PRKCD;ARRB1;JAK2,,,,,,,,,,
Notch signaling pathway,2/59,0.003765310255895,0.025980640765677,0,0,24.0919540229885,134.479480841414,TLE4;EP300,,,,,,,,,,
Thromboxane A2 receptor signaling,2/56,0.00339879969708,0.02628021601041,0,0,25.4342273307791,144.576616218793,PRKCB;PRKCD,,,,,,,,,,
Keratinocyte differentiation,2/57,0.003519003283445,0.02628021601041,0,0,24.9705329153605,141.072960611524,PRKCB;PRKCD,,,,,,,,,,
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha,2/57,0.003519003283445,0.02628021601041,0,0,24.9705329153605,141.072960611524,PRKCB;EP300,,,,,,,,,,
Signaling events mediated by VEGFR1 and VEGFR2 Homo sapiens d6f6ae1f-6195-11e5-8ac5-06603eb7f303,2/68,0.004969858929348,0.026603362504159,0,0,20.7972831765935,110.316356513446,PRKCB;PRKCD,,,,,,,,,,
Adipokines and Cytokines in Insulin Resistance in Skeletal Muscles,2/53,0.003050060586094,0.026805340150866,0,0,26.9344151453685,156.020126831303,PRKCD;JAK2,,,,,,,,,,
down HS 30min LPS vs ctrl RAW264.7 macrophage (Mouse) [20222745],2/75,0.006013544320434,0.027077922038453,0,0,18.796410014171,96.1199719235846,PRKCD;TLK1,,,,,,,,,,
up 240min BMP4 vs ctrl hESC (Human) [19664995],3/229,0.005257024260417,0.027077922038453,0,0,9.35982932996207,49.1221640229001,TLE4;CTR9;TLK1,,,,,,,,,,
down 30min BMP4 vs ctrl hESC (Human) [19664995],4/488,0.006536050147213,0.027077922038453,0,0,5.96418732782369,30.0023806310387,ZMYND8;CTR9;EP300;NAP1L1,,,,,,,,,,
up 10min PPase inhibitors vs ctrl Hepa1-6 (Mouse) [18846507],6/1098,0.006096027451059,0.027077922038453,0,0,4.14879120879121,21.159324545797,PRKAB2;MBD5;ZMYND8;CTR9;TLK1;STK4,,,,,,,,,,
G0/G1 Cell Cycle Phase Transition Activation in Cancer,2/54,0.003164322327735,0.02728481705236,0,0,26.4151193633952,152.040576203559,EP300;JAK2,,,,,,,,,,
Immune system,6/998,0.003828677106909,0.027657223709006,0,0,4.59120967741935,25.5511650972773,CDH1;PRKCB;ZBTB16;PRKCD;EP300;JAK2,,,,,,,,,,
YES1,1/7,0.010801182772693,0.02773290857814,0,0,110.905555555556,502.191405614873,PRKCD,,,,,,,,,,
PRKD2,1/8,0.012334969042911,0.02773290857814,0,0,95.0571428571429,417.80627965005,HDAC5,,,,,,,,,,
PAK3,1/8,0.012334969042911,0.02773290857814,0,0,95.0571428571429,417.80627965005,STK4,,,,,,,,,,
DYRK1B,1/8,0.012334969042911,0.02773290857814,0,0,95.0571428571429,417.80627965005,HDAC5,,,,,,,,,,
JAK3,1/9,0.01386645428907,0.02773290857814,0,0,83.1708333333333,355.828338741317,JAK2,,,,,,,,,,
MAP3K7,1/9,0.01386645428907,0.02773290857814,0,0,83.1708333333333,355.828338741317,HDAC5,,,,,,,,,,
ABL1,2/94,0.009300873946985,0.02773290857814,0,0,14.900299850075,69.6983415583919,PRKCD;JAK2,,,,,,,,,,
FYN,2/115,0.013670111885886,0.02773290857814,0,0,12.1184009765029,52.0187626574392,MAX;PRKCD,,,,,,,,,,
CSNK2A1,3/286,0.009675787516957,0.02773290857814,0,0,7.45305401312468,34.5682233205261,MAX;CDH1;VDR,,,,,,,,,,
MAPK1,3/326,0.013763866390065,0.02773290857814,0,0,6.51680672268908,27.9291339531842,EP300;ARRB1;JAK2,,,,,,,,,,
CDK2,4/553,0.010064294583444,0.02773290857814,0,0,5.24050462119679,24.0998298886741,PRKCB;ZMYND8;ZBTB16;TLK1,,,,,,,,,,
Th1-Cell Function in Systemic Lupus Erythematosus,2/55,0.003280570706943,0.027763348390242,0,0,25.9154196486662,148.229407329197,PRKCD;JAK2,,,,,,,,,,
Apoptotic cleavage of cellular proteins Homo sapiens R-HSA-111465,2/37,0.001497023535475,0.028148372973224,0,0,39.2788177339901,255.480289245992,CDH1;PRKCD,,,,,,,,,,
Regulation of TP53 Activity Homo sapiens R-HSA-5633007,3/151,0.001623944594609,0.028148372973224,0,0,14.3491795366795,92.1633044147547,PRKAB2;KAT6A;EP300,,,,,,,,,,
VEGFA-VEGFR2 Pathway Homo sapiens R-HSA-4420097,4/320,0.001438965859585,0.028148372973224,0,0,9.21378340365682,60.2934375616888,PRKCB;PRKCD;ARRB1;JAK2,,,,,,,,,,
Signaling by VEGF Homo sapiens R-HSA-194138,4/328,0.001575427895562,0.028148372973224,0,0,8.98262459990855,57.9669278502267,PRKCB;PRKCD;ARRB1;JAK2,,,,,,,,,,
Hemostasis Homo sapiens R-HSA-109582,5/552,0.001475117249051,0.028148372973224,0,0,6.82815356489945,44.5128546407331,PRKCB;PRKCD;EP300;ARRB1;JAK2,,,,,,,,,,
Non-small cell lung cancer WP4255,2/72,0.005554958275975,0.028157891950634,0,0,19.6049261083744,101.809643190955,PRKCB;STK4,,,,,,,,,,
Neutrophil Chemotaxis,2/56,0.00339879969708,0.028240935664825,0,0,25.4342273307791,144.576616218793,PRKCB;PRKCD,,,,,,,,,,
down HS 3min LPS vs ctrl RAW264.7 macrophage (Mouse) [20222745],2/83,0.007317980393163,0.028296190853563,0,0,16.9331630481056,83.2674897344772,PRKCD;TLK1,,,,,,,,,,
PKMTs methylate histone lysines Homo sapiens R-HSA-3214841,2/40,0.001748207723605,0.028408375508573,0,0,36.1724137931034,229.664593734864,ATF7IP;KMT2A,,,,,,,,,,
Neutrophil Activation via Adherence on Endothelial Cells,2/57,0.003519003283445,0.028717580366686,0,0,24.9705329153605,141.072960611524,PRKCB;PRKCD,,,,,,,,,,
Circadian rhythm,2/62,0.004149430576332,0.02880601347047,0,0,22.883908045977,125.513296476479,CHD9;EP300,,,,,,,,,,
Antigen-activated B-cell receptor generation of second messengers,3/211,0.004185489136735,0.02880601347047,0,0,10.1790865384615,55.7420185041041,MAX;PRKCB;PRKCD,,,,,,,,,,
GnRH secretion,2/64,0.0044152146158,0.029014267475258,0,0,22.1434927697442,120.077492456558,PRKCB;ARRB1,,,,,,,,,,
Proteins with Altered Expression in Cancer-Associated Evading of Growth Suppressors,2/58,0.003641175466029,0.029193283999568,0,0,24.5233990147783,137.70988958886,CDH1;STK4,,,,,,,,,,
TRAF2,3/279,0.009045856197343,0.02936424088676,0,0,7.64479813664596,35.972203962155,ZBTB16;PRKCD;NAP1L1,,,,,,,,,,
Steroids Induced Cataract,2/59,0.003765310255895,0.029639509438501,0,0,24.0919540229885,134.479480841414,CDH1;EP300,,,,,,,,,,
Proliferative Diabetic Retinopathy,2/60,0.003891401676827,0.029639509438501,0,0,23.6753864447087,131.374384564875,PRKCB;JAK2,,,,,,,,,,
Mucinous Ovarian Carcinoma,2/60,0.003891401676827,0.029639509438501,0,0,23.6753864447087,131.374384564875,EP300;JAK2,,,,,,,,,,
STK4,1/10,0.015395641764485,0.029729515131419,0,0,73.9259259259259,308.542479281304,STK4,,,,,,,,,,
Proteins Involved in Diffuse Large-B-Cell Lymphoma,2/61,0.004019443767471,0.030112881995644,0,0,23.2729398012858,128.387773216608,KMT2A;PRKCB,,,,,,,,,,
Long-term potentiation,2/67,0.004828328046459,0.030286785018696,0,0,21.1183023872679,112.629292461489,PRKCB;EP300,,,,,,,,,,
Neutrophil Degranulation via FPR1 Signaling,2/62,0.004149430576332,0.030585318925546,0,0,22.883908045977,125.513296476479,PRKCD;PADI4,,,,,,,,,,
Adipocytokine signaling pathway,2/69,0.005113293237097,0.030663369683384,0,0,20.4858466289243,108.081516136767,PRKAB2;JAK2,,,,,,,,,,
Adherens junction,2/71,0.005405848740218,0.030663369683384,0,0,19.8900549725137,103.831533082331,CDH1;EP300,,,,,,,,,,
Non-small cell lung cancer,2/72,0.005554958275975,0.030663369683384,0,0,19.6049261083744,101.809643190955,PRKCB;STK4,,,,,,,,,,
Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway,2/64,0.0044152146158,0.031527391865948,0,0,22.1434927697442,120.077492456558,EP300;JAK2,,,,,,,,,,
Neutrophil Degranulation via FPR1/IL8,2/64,0.0044152146158,0.031527391865948,0,0,22.1434927697442,120.077492456558,PRKCB;PRKCD,,,,,,,,,,
Regulatory circuits of the STAT3 signaling pathway WP4538,2/78,0.006488895136943,0.031795586171019,0,0,18.051724137931,90.938502840842,PRKCB;JAK2,,,,,,,,,,
G alpha 13 pathway,2/67,0.004828328046459,0.031963776309301,0,0,21.1183023872679,112.629292461489,PRKCB;PRKCD,,,,,,,,,,
Adipocytokine signaling pathway,2/67,0.004828328046459,0.031963776309301,0,0,21.1183023872679,112.629292461489,PRKAB2;JAK2,,,,,,,,,,
G alpha q pathway,2/70,0.00525862511957,0.031963776309301,0,0,20.183569979716,105.921067676316,PRKCB;PRKCD,,,,,,,,,,
Signaling events mediated by VEGFR1 and VEGFR2,2/70,0.00525862511957,0.031963776309301,0,0,20.183569979716,105.921067676316,PRKCB;PRKCD,,,,,,,,,,
Long-term potentiation,2/70,0.00525862511957,0.031963776309301,0,0,20.183569979716,105.921067676316,PRKCB;EP300,,,,,,,,,,
Interleukin-6 signaling pathway,2/71,0.005405848740218,0.031963776309301,0,0,19.8900549725137,103.831533082331,PRKCD;JAK2,,,,,,,,,,
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family,2/71,0.005405848740218,0.031963776309301,0,0,19.8900549725137,103.831533082331,PRKCB;PRKCD,,,,,,,,,,
Leishmaniasis,2/72,0.005554958275975,0.031963776309301,0,0,19.6049261083744,101.809643190955,PRKCB;JAK2,,,,,,,,,,
Myocyte adrenergic pathway,2/72,0.005554958275975,0.031963776309301,0,0,19.6049261083744,101.809643190955,ZMYND8;ARRB1,,,,,,,,,,
Cell cycle,4/453,0.005034830477264,0.031963776309301,0,0,6.44065000412439,34.0798971350966,HDAC5;MAX;CDH1;EP300,,,,,,,,,,
B-Cell Activation in Systemic Lupus Erythematosus,2/65,0.004551000008971,0.031997030832306,0,0,21.7909140667761,117.505505616264,PRKCB;JAK2,,,,,,,,,,
Myc repressed pathway,2/73,0.005705947915147,0.032131921288427,0,0,19.3278290432249,99.8523224658666,MAX;EP300,,,,,,,,,,
Adherens junction cell adhesion,2/74,0.005858811858858,0.032131921288427,0,0,19.0584291187739,97.9566750362467,CDH1;EP300,,,,,,,,,,
Wnt/calcium/cyclic GMP pathway,2/74,0.005858811858858,0.032131921288427,0,0,19.0584291187739,97.9566750362467,PRKCB;PRKCD,,,,,,,,,,
Bacterial invasion of epithelial cells,2/77,0.00632859171525,0.032346135433502,0,0,18.2933333333333,92.6132478975765,CDH1;ACTR3B,,,,,,,,,,
Leishmaniasis,2/77,0.00632859171525,0.032346135433502,0,0,18.2933333333333,92.6132478975765,PRKCB;JAK2,,,,,,,,,,
Neutrophil Recruitment and Priming,2/66,0.004688706448143,0.032465740103048,0,0,21.4493534482759,115.024271597146,PRKCB;JAK2,,,,,,,,,,
down 4h cisplatin vs ctrl mESC (Mouse) [22006019],4/535,0.008985663051764,0.032573028562644,0,0,5.4231708167678,25.5546586008931,ATF7IP;HDAC5;CDH1;TET2,,,,,,,,,,
Monkeypox virus ser/thr protein kinase-like protein,3/105,0.000567912084763,0.032900179637754,0,0,20.8686974789916,155.963127403877,PRKCB;PRKCD;EP300,,,,,,,,,,
STAT3 and NFkB Activate Inflammation-Induced Tumorigenesis,2/67,0.004828328046459,0.032933521152712,0,0,21.1183023872679,112.629292461489,CDH1;JAK2,,,,,,,,,,
Human group 1 coronavirus associated with pneumonia ORF 1a,3/106,0.000583841527305,0.033071378957773,0,0,20.6650485436893,153.869491681428,APOBEC3C;UIMC1;EP300,,,,,,,,,,
Human coronavirus 229E full_polyprotein 1..4085,3/107,0.000600054456691,0.033229557159017,0,0,20.4653159340659,151.821744585802,APOBEC3C;UIMC1;EP300,,,,,,,,,,
Monkeypox virus ankyrin-like protein,7/978,0.000612706624745,0.033229557159017,0,0,5.7065739787161,42.2150904825682,MBD5;KMT2A;PRKCB;PRKCD;EP300;STK4;JAK2,,,,,,,,,,
G alpha (z) signalling events Homo sapiens R-HSA-418597,2/46,0.00230636321186,0.033314135282429,0,0,31.230407523511,189.63363791907,PRKCB;PRKCD,,,,,,,,,,
Validated targets of C-MYC transcriptional activation Homo sapiens 61d3b115-6196-11e5-8ac5-06603eb7f303,2/79,0.006651044056184,0.033624722728484,0,0,17.8163905060457,89.3132348581285,MAX;EP300,,,,,,,,,,
Mitochondrial biogenesis Homo sapiens R-HSA-1592230,2/49,0.002613000983113,0.033810915041701,0,0,29.2325752017608,173.853605814568,PRKAB2;CHD9,,,,,,,,,,
Apoptotic execution  phase Homo sapiens R-HSA-75153,2/51,0.002827521187027,0.033810915041701,0,0,28.036593947924,164.528682262451,CDH1;PRKCD,,,,,,,,,,
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants Homo sapiens R-HSA-2894862,2/57,0.003519003283445,0.033810915041701,0,0,24.9705329153605,141.072960611524,HDAC5;EP300,,,,,,,,,,
Signaling by NOTCH1 in Cancer Homo sapiens R-HSA-2644603,2/57,0.003519003283445,0.033810915041701,0,0,24.9705329153605,141.072960611524,HDAC5;EP300,,,,,,,,,,
Signaling by NOTCH1 PEST Domain Mutants in Cancer Homo sapiens R-HSA-2644602,2/57,0.003519003283445,0.033810915041701,0,0,24.9705329153605,141.072960611524,HDAC5;EP300,,,,,,,,,,
Constitutive Signaling by NOTCH1 PEST Domain Mutants Homo sapiens R-HSA-2644606,2/57,0.003519003283445,0.033810915041701,0,0,24.9705329153605,141.072960611524,HDAC5;EP300,,,,,,,,,,
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer Homo sapiens R-HSA-2894858,2/57,0.003519003283445,0.033810915041701,0,0,24.9705329153605,141.072960611524,HDAC5;EP300,,,,,,,,,,
Formation of the beta-catenin:TCF transactivating complex Homo sapiens R-HSA-201722,2/58,0.003641175466029,0.033810915041701,0,0,24.5233990147783,137.70988958886,TLE4;EP300,,,,,,,,,,
Gene Expression Homo sapiens R-HSA-74160,8/1631,0.00276749006883,0.033810915041701,0,0,3.93174207720539,23.1572314253674,PRKAB2;CHD9;VDR;KAT6A;PRKCD;TET2;EP300;JARID2,,,,,,,,,,
Signal Transduction Homo sapiens R-HSA-162582,10/2465,0.003027176856364,0.033810915041701,0,0,3.39714867617108,19.7038863687175,TLE4;HDAC5;PRKAB2;CDH1;PRKCB;PRKCD;EP300;ARRB1;STK4;JAK2,,,,,,,,,,
Transcriptional regulation of white adipocyte differentiation,2/77,0.00632859171525,0.034174395262352,0,0,18.2933333333333,92.6132478975765,CHD9;EP300,,,,,,,,,,
B-Cells Function in Systemic Scleroderma,2/69,0.005113293237097,0.034364338372842,0,0,20.4858466289243,108.081516136767,PRKCB;JAK2,,,,,,,,,,
MicroRNAs in cardiomyocyte hypertrophy WP1544,2/84,0.007489271172557,0.034403839448934,0,0,16.7258200168209,81.8609098316623,HDAC5;PRKCB,,,,,,,,,,
EGFR Tyrosine Kinase Inhibitor Resistance WP4806,2/84,0.007489271172557,0.034403839448934,0,0,16.7258200168209,81.8609098316623,PRKCB;JAK2,,,,,,,,,,
CSNK2A1,4/564,0.010763467820731,0.034410480457185,0,0,5.13465608465608,23.2681946149723,MAX;CDH1;VDR;ARRB1,,,,,,,,,,
MARK2,1/12,0.018447136470887,0.034434654745657,0,0,60.4787878787879,241.482493848957,HDAC5,,,,,,,,,,
Low-Grade Serous Ovarian Carcinoma,2/70,0.00525862511957,0.034828864922371,0,0,20.183569979716,105.921067676316,EP300;JAK2,,,,,,,,,,
PTPN6,1/19,0.029055470008619,0.034866564010343,0,0,36.9462962962963,130.736261970552,JAK2,,,,,,,,,,
PTPN11,1/21,0.032065988516399,0.034981078381526,0,0,33.2483333333333,114.37291539919,JAK2,,,,,,,,,,
Humoral Immunity in Vitiligo,2/71,0.005405848740218,0.035258554612788,0,0,19.8900549725137,103.831533082331,PRKCB;JAK2,,,,,,,,,,
Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway,2/72,0.005554958275975,0.035258554612788,0,0,19.6049261083744,101.809643190955,CDH1;JAK2,,,,,,,,,,
Glioma Stem Cell Program Activation,2/72,0.005554958275975,0.035258554612788,0,0,19.6049261083744,101.809643190955,EP300;JAK2,,,,,,,,,,
Fc epsilon receptor I signaling pathway,2/79,0.006651044056184,0.035371461571523,0,0,17.8163905060457,89.3132348581285,PRKCB;PRKCD,,,,,,,,,,
PKN1,1/13,0.019969450260865,0.036073845632531,0,0,55.4361111111111,216.952084672946,HDAC5,,,,,,,,,,
TAM Receptor Signaling Activation in Cancer,2/74,0.005858811858858,0.036182121885112,0,0,19.0584291187739,97.9566750362467,CDH1;PRKCB,,,,,,,,,,
Proteins Involved in Melanoma,3/238,0.005849326949877,0.036182121885112,0,0,8.99726443768997,46.2587933824383,CDH1;VDR;PRKCB,,,,,,,,,,
Human coronavirus 229E full_polyprotein 1..6758,3/112,0.000685443789319,0.036399921228604,0,0,19.521625163827,142.223708127648,APOBEC3C;UIMC1;EP300,,,,,,,,,,
AMPK inhibition of chREBP transcriptional activation activity,1/5,0.007726694289036,0.037151639663721,0,0,166.375,809.093962505696,PRKAB2,,,,,,,,,,
Phospholipase C delta-1 interactions in phospholipid-associated cell signaling,1/5,0.007726694289036,0.037151639663721,0,0,166.375,809.093962505696,PRKCB,,,,,,,,,,
Ion channel and phorbal esters signaling pathway,1/5,0.007726694289036,0.037151639663721,0,0,166.375,809.093962505696,PRKCB,,,,,,,,,,
Disinhibition of SNARE formation,1/5,0.007726694289036,0.037151639663721,0,0,166.375,809.093962505696,PRKCB,,,,,,,,,,
T cell signal transduction,2/83,0.007317980393163,0.037151639663721,0,0,16.9331630481056,83.2674897344772,PRKCB;PRKCD,,,,,,,,,,
MicroRNAs in cardiomyocyte hypertrophy,2/85,0.007662373287067,0.037151639663721,0,0,16.5234732031575,80.4930011397507,HDAC5;PRKCB,,,,,,,,,,
Myc active pathway,2/85,0.007662373287067,0.037151639663721,0,0,16.5234732031575,80.4930011397507,MAX;EP300,,,,,,,,,,
Endometrioid Ovarian Carcinoma,2/76,0.006170139526936,0.037596716850798,0,0,18.5414725069897,94.3396393282362,EP300;JAK2,,,,,,,,,,
Circadian Clock Homo sapiens R-HSA-400253,2/63,0.004281356167812,0.038384572539002,0,0,22.5076314301865,122.745040697201,CHD9;EP300,,,,,,,,,,
Angiogenesis Homo sapiens P00005,2/142,0.020345056327914,0.038429550841616,0,0,9.7679802955665,38.0454757215126,PRKCB;PRKCD,,,,,,,,,,
JAK/STAT signaling pathway Homo sapiens P00038,1/14,0.021489479385557,0.038454857847838,0,0,51.1692307692308,196.499660131609,JAK2,,,,,,,,,,
ESR1,4/591,0.012612068526473,0.039718603866952,0,0,4.89166508928008,21.3917460017411,HDAC5;CHD9;ZBTB16;EP300,,,,,,,,,,
Proplatelet Maturation,2/79,0.006651044056184,0.039993778074684,0,0,17.8163905060457,89.3132348581285,ZBTB16;JAK2,,,,,,,,,,
G Protein Signaling Pathways WP35,2/93,0.009111722662176,0.040588582767875,0,0,15.0647972716938,70.7773324677565,PRKCB;PRKCD,,,,,,,,,,
Atopic Dermatitis,2/81,0.00698085549842,0.04084720025862,0,0,17.3635966826713,86.2030308955848,CDH1;JAK2,,,,,,,,,,
Clear Cell Ovarian Carcinoma,2/81,0.00698085549842,0.04084720025862,0,0,17.3635966826713,86.2030308955848,EP300;JAK2,,,,,,,,,,
High-Grade Serous Ovarian Carcinoma,2/82,0.007148506609489,0.04084720025862,0,0,17.1456896551724,84.7143117646977,EP300;JAK2,,,,,,,,,,
Proteins Involved in Endometriosis,3/256,0.007150494574813,0.04084720025862,0,0,8.34952004517222,41.2514195883804,CDH1;VDR;PRKCB,,,,,,,,,,
Neural crest differentiation,2/91,0.008738708384625,0.041449819500047,0,0,15.4048818287485,73.0190302211722,HDAC5;CDH1,,,,,,,,,,
Insulin signaling pathway,3/277,0.008870468539665,0.041513792765632,0,0,7.70138164754953,36.3892413133181,PRKAB2;PRKCB;PRKCD,,,,,,,,,,
Acetylation and Deacetylation of RelA in Nucleus Homo sapiens h RELAPathway,1/5,0.007726694289036,0.041944911854767,0,0,166.375,809.093962505696,EP300,,,,,,,,,,
Pelp1 Modulation of Estrogen Receptor Activity Homo sapiens h pelp1Pathway,1/5,0.007726694289036,0.041944911854767,0,0,166.375,809.093962505696,EP300,,,,,,,,,,
Interleukin-2 signaling pathway,5/847,0.009154551492849,0.042279573341976,0,0,4.36849077288507,20.5035293204096,PRKCB;ZBTB16;PRKCD;TLK1;JAK2,,,,,,,,,,
Fc gamma receptor-mediated phagocytosis,2/94,0.009300873946985,0.042397490329765,0,0,14.900299850075,69.6983415583919,PRKCB;PRKCD,,,,,,,,,,
CHRNA7 -> IL8 Production,1/5,0.007726694289036,0.042543364940837,0,0,166.375,809.093962505696,JAK2,,,,,,,,,,
ARRB1/ARRB2 and GPCRs Internalization,1/5,0.007726694289036,0.042543364940837,0,0,166.375,809.093962505696,ARRB1,,,,,,,,,,
Genes with Mutations Associated with Osteoporosis,1/5,0.007726694289036,0.042543364940837,0,0,166.375,809.093962505696,VDR,,,,,,,,,,
MAPK3,3/326,0.013763866390065,0.042708467769173,0,0,6.51680672268908,27.9291339531842,PRKCD;ARRB1;JAK2,,,,,,,,,,
G-protein signaling pathways,2/95,0.009491780601043,0.042713012704695,0,0,14.7393400074156,68.6459564646304,PRKCB;PRKCD,,,,,,,,,,
Morphine addiction,2/91,0.008738708384625,0.043069348467082,0,0,15.4048818287485,73.0190302211722,PRKCB;ARRB1,,,,,,,,,,
GnRH signaling pathway,2/93,0.009111722662176,0.043359231978631,0,0,15.0647972716938,70.7773324677565,PRKCB;PRKCD,,,,,,,,,,
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family,2/97,0.009878837910766,0.043892051983277,0,0,14.4275862068966,66.6173651400737,PRKCB;PRKCD,,,,,,,,,,
M-cell: Motilin Release,1/6,0.009265092249714,0.044569970085469,0,0,133.093333333333,623.076634648791,ARRB1,,,,,,,,,,
Prolactin Induced Dopamin Synthesis by TIDA Neurons (Negative Feedback),1/6,0.009265092249714,0.044569970085469,0,0,133.093333333333,623.076634648791,JAK2,,,,,,,,,,
Vitamin D and Folate in Multiple Sclerosis,1/6,0.009265092249714,0.044569970085469,0,0,133.093333333333,623.076634648791,VDR,,,,,,,,,,
IGF1R -> ARRB1/ERK1/3 Signaling,1/6,0.009265092249714,0.044569970085469,0,0,133.093333333333,623.076634648791,ARRB1,,,,,,,,,,
IL11R -> STAT3 Signaling,1/6,0.009265092249714,0.044569970085469,0,0,133.093333333333,623.076634648791,JAK2,,,,,,,,,,
KIT -> STAT Signaling,1/6,0.009265092249714,0.044569970085469,0,0,133.093333333333,623.076634648791,JAK2,,,,,,,,,,
Genes with Mutations Associated with Urolithiasis,1/6,0.009265092249714,0.044569970085469,0,0,133.093333333333,623.076634648791,VDR,,,,,,,,,,
Epithelial to Mesenchymal Transition in Cancer: Overview,2/90,0.00855485651156,0.044569970085469,0,0,15.5807210031348,74.1838036079248,CDH1;JAK2,,,,,,,,,,
Diffuse Large-B-Cell Lymphoma,2/91,0.008738708384625,0.044569970085469,0,0,15.4048818287485,73.0190302211722,EP300;JAK2,,,,,,,,,,
Endometrioid Endometrial Cancer,2/92,0.008924332290442,0.044569970085469,0,0,15.2329501915709,71.8838923558232,EP300;JAK2,,,,,,,,,,
Proteins Involved in Spontaneous Abortion,2/93,0.009111722662176,0.044569970085469,0,0,15.0647972716938,70.7773324677565,CDH1;EP300,,,,,,,,,,
ESR1/ERBB Positive Luminal Breast Cancer,2/93,0.009111722662176,0.044569970085469,0,0,15.0647972716938,70.7773324677565,EP300;JAK2,,,,,,,,,,
ATM,2/161,0.025705110574775,0.044983943505857,0,0,8.59249620472782,31.457690999855,UIMC1;EP300,,,,,,,,,,
Gamma-secretase-mediated ErbB4 signaling pathway,1/7,0.010801182772693,0.045133513728751,0,0,110.905555555556,502.191405614873,PRKCB,,,,,,,,,,
Activation of PKC through G-protein coupled receptors,1/7,0.010801182772693,0.045133513728751,0,0,110.905555555556,502.191405614873,PRKCB,,,,,,,,,,
PELP1 modulation of estrogen receptor activity,1/7,0.010801182772693,0.045133513728751,0,0,110.905555555556,502.191405614873,EP300,,,,,,,,,,
GnRH signaling pathway,2/101,0.010673774444414,0.045133513728751,0,0,13.8418669453152,62.8415988385954,PRKCB;PRKCD,,,,,,,,,,
Melanogenesis,2/101,0.010673774444414,0.045133513728751,0,0,13.8418669453152,62.8415988385954,PRKCB;EP300,,,,,,,,,,
SPATA1,2/25,0.000682184965402,0.045365300199233,0,0,59.808095952024,436.013562840355,EP300;TLK1,,,,,,,,,,
IFN gamma signaling pathway  Homo sapiens h ifngPathway,1/6,0.009265092249714,0.045990249085629,0,0,133.093333333333,623.076634648791,JAK2,,,,,,,,,,
CBL mediated ligand-induced downregulation of EGF receptors Homo sapiens h cblPathway,1/8,0.012334969042911,0.045990249085629,0,0,95.0571428571429,417.80627965005,PRKCB,,,,,,,,,,
g-Secretase mediated ErbB4 Signaling Pathway  Homo sapiens h erbB4pathway,1/8,0.012334969042911,0.045990249085629,0,0,95.0571428571429,417.80627965005,PRKCB,,,,,,,,,,
SUMOylation as a mechanism to modulate CtBP-dependent gene responses Homo sapiens h ctbp1Pathway,1/8,0.012334969042911,0.045990249085629,0,0,95.0571428571429,417.80627965005,CDH1,,,,,,,,,,
Stat3 Signaling Pathway Homo sapiens h stat3Pathway,1/8,0.012334969042911,0.045990249085629,0,0,95.0571428571429,417.80627965005,JAK2,,,,,,,,,,
NO2-dependent IL 12 Pathway in NK cells Homo sapiens h no2il12Pathway,1/9,0.01386645428907,0.045990249085629,0,0,83.1708333333333,355.828338741317,JAK2,,,,,,,,,,
Role of PPAR-gamma Coactivators in Obesity and Thermogenesis Homo sapiens h ppargPathway,1/9,0.01386645428907,0.045990249085629,0,0,83.1708333333333,355.828338741317,EP300,,,,,,,,,,
Reversal of Insulin Resistance by Leptin Homo sapiens h leptinPathway,1/10,0.015395641764485,0.045990249085629,0,0,73.9259259259259,308.542479281304,PRKAB2,,,,,,,,,,
Overview of telomerase protein component gene hTert Transcriptional Regulation  Homo sapiens h tertpathway,1/10,0.015395641764485,0.045990249085629,0,0,73.9259259259259,308.542479281304,MAX,,,,,,,,,,
Activation of PKC through G-protein coupled receptors Homo sapiens h pkcPathway,1/11,0.016922534733464,0.045990249085629,0,0,66.53,271.383130357804,PRKCB,,,,,,,,,,
EPO Signaling Pathway Homo sapiens h epoPathway,1/11,0.016922534733464,0.045990249085629,0,0,66.53,271.383130357804,JAK2,,,,,,,,,,
Cell to Cell Adhesion Signaling Homo sapiens h cell2cellPathway,1/12,0.018447136470887,0.045990249085629,0,0,60.4787878787879,241.482493848957,CDH1,,,,,,,,,,
CARM1 and Regulation of the Estrogen Receptor Homo sapiens h carm-erPathway,1/12,0.018447136470887,0.045990249085629,0,0,60.4787878787879,241.482493848957,EP300,,,,,,,,,,
IL 3 signaling pathway Homo sapiens h il3Pathway,1/12,0.018447136470887,0.045990249085629,0,0,60.4787878787879,241.482493848957,JAK2,,,,,,,,,,
Visual Signal Transduction Homo sapiens h rhodopsinPathway,1/13,0.019969450260865,0.045990249085629,0,0,55.4361111111111,216.952084672946,ARRB1,,,,,,,,,,
Effects of calcineurin in Keratinocyte Differentiation Homo sapiens h calcineurinPathway,1/13,0.019969450260865,0.045990249085629,0,0,55.4361111111111,216.952084672946,PRKCB,,,,,,,,,,
Trka Receptor Signaling Pathway Homo sapiens h trkaPathway,1/13,0.019969450260865,0.045990249085629,0,0,55.4361111111111,216.952084672946,PRKCB,,,,,,,,,,
IL 6 signaling pathway Homo sapiens h il6Pathway,1/13,0.019969450260865,0.045990249085629,0,0,55.4361111111111,216.952084672946,JAK2,,,,,,,,,,
Melanocyte Development and Pigmentation Pathway Homo sapiens h melanocytepathway,1/13,0.019969450260865,0.045990249085629,0,0,55.4361111111111,216.952084672946,EP300,,,,,,,,,,
PLCG2,2/121,0.015053614496343,0.046033516793164,0,0,11.5039119095914,48.2719921428208,PRKCB;JAK2,,,,,,,,,,
Neural Crest Differentiation WP2064,2/101,0.010673774444414,0.046148377744965,0,0,13.8418669453152,62.8415988385954,HDAC5;CDH1,,,,,,,,,,
Inflammatory mediator regulation of TRP channels,2/98,0.010074977542144,0.04634489669386,0,0,14.2765804597701,65.6394396936512,PRKCB;PRKCD,,,,,,,,,,
Interleukin-4 signaling pathway,2/104,0.011288023602033,0.046612897462511,0,0,13.4327248140636,60.2325123362261,EP300;JAK2,,,,,,,,,,
PDGFRB,1/18,0.02754681494067,0.046746110202348,0,0,39.121568627451,140.519524554554,PRKCD,,,,,,,,,,
Fibroblast growth factor receptor pathway,2/105,0.011496181765015,0.046920462785118,0,0,13.301640441915,59.4016720326606,PRKCB;PRKCD,,,,,,,,,,
Follicular Lymphoma,2/97,0.009878837910766,0.04702738463771,0,0,14.4275862068966,66.6173651400737,EP300;JAK2,,,,,,,,,,
PIK3CA,2/125,0.016008223510813,0.047479707075168,0,0,11.1275581721334,46.0085886561767,PRKCD;JAK2,,,,,,,,,,
KAT5,2/126,0.016250862229296,0.047479707075168,0,0,11.0372636262514,45.4692140065264,MAX;EP300,,,,,,,,,,
HDAC4,2/127,0.016495085178776,0.047479707075168,0,0,10.9484137931034,44.9398753818362,HDAC5;ZBTB16,,,,,,,,,,
CDH1,2/127,0.016495085178776,0.047479707075168,0,0,10.9484137931034,44.9398753818362,CDH1;EP300,,,,,,,,,,
BTK,2/128,0.016740887201567,0.047479707075168,0,0,10.8609742747674,44.4203118979461,PRKCB;JAK2,,,,,,,,,,
MAPK8,3/352,0.016876673130984,0.047479707075168,0,0,6.02333196889071,24.5861743567025,UIMC1;PRKCD;STK4,,,,,,,,,,
Melanogenesis,2/101,0.010673774444414,0.047515512042874,0,0,13.8418669453152,62.8415988385954,PRKCB;EP300,,,,,,,,,,
down 240min BMP4 vs ctrl hESC (Human) [19664995],4/610,0.014028843552892,0.047863113298102,0,0,4.73365114289207,20.1967844365891,ZMYND8;EP300;NAP1L1;JARID2,,,,,,,,,,
ROS in Neutrophil Mediated Cell Damage,1/7,0.010801182772693,0.047923694438064,0,0,110.905555555556,502.191405614873,JAK2,,,,,,,,,,
CSF2 -> STAT Signaling,1/7,0.010801182772693,0.047923694438064,0,0,110.905555555556,502.191405614873,JAK2,,,,,,,,,,
Ca2+ Absorption Decline in Intestine in Osteoporosis,1/7,0.010801182772693,0.047923694438064,0,0,110.905555555556,502.191405614873,VDR,,,,,,,,,,
Ca2+ Reabsorption Decline in Kidney,1/7,0.010801182772693,0.047923694438064,0,0,110.905555555556,502.191405614873,VDR,,,,,,,,,,
IL6ST -> STAT5B Signaling,1/7,0.010801182772693,0.047923694438064,0,0,110.905555555556,502.191405614873,JAK2,,,,,,,,,,
Folate Cycle and Homocysteine Overproduction,1/7,0.010801182772693,0.047923694438064,0,0,110.905555555556,502.191405614873,VDR,,,,,,,,,,
IL6 Overexpression After Contraction in Skeletal Muscles in Muscular Dystrophies,1/7,0.010801182772693,0.047923694438064,0,0,110.905555555556,502.191405614873,EP300,,,,,,,,,,
Transcription Regulation by Methyltransferase of CARM1 Homo sapiens h carm1Pathway,1/14,0.021489479385557,0.048035306861832,0,0,51.1692307692308,196.499660131609,EP300,,,,,,,,,,
Import of palmitoyl-CoA into the mitochondrial matrix,1/8,0.012334969042911,0.048106379267354,0,0,95.0571428571429,417.80627965005,PRKAB2,,,,,,,,,,
Stabilization of mRNA by HuR,1/8,0.012334969042911,0.048106379267354,0,0,95.0571428571429,417.80627965005,PRKCD,,,,,,,,,,
Vitamin D biosynthesis,1/8,0.012334969042911,0.048106379267354,0,0,95.0571428571429,417.80627965005,VDR,,,,,,,,,,
G alpha i pathway,2/108,0.012130805822615,0.048106379267354,0,0,12.9232270657124,57.0173699052305,PRKCB;PRKCD,,,,,,,,,,
IL12 and Stat4 Dependent Signaling Pathway in Th1 Development Homo sapiens h IL12Pathway,1/15,0.023007227131929,0.048570812834072,0,0,47.5119047619048,179.212381370596,JAK2,,,,,,,,,,
IL-7 Signal Transduction Homo sapiens h il7Pathway,1/15,0.023007227131929,0.048570812834072,0,0,47.5119047619048,179.212381370596,EP300,,,,,,,,,,
Hypoxia-Inducible Factor in the Cardiovascular System Homo sapiens h hifPathway,1/16,0.024522696784534,0.048687393848625,0,0,44.3422222222222,164.427885851853,EP300,,,,,,,,,,
Cadmium induces DNA synthesis and proliferation in macrophages Homo sapiens h cdMacPathway,1/16,0.024522696784534,0.048687393848625,0,0,44.3422222222222,164.427885851853,PRKCB,,,,,,,,,,
Map Kinase Inactivation of SMRT Corepressor Homo sapiens h egfr smrtePathway,1/17,0.026035891626597,0.048687393848625,0,0,41.56875,151.654407895734,ZBTB16,,,,,,,,,,
Aspirin Blocks Signaling Pathway Involved in Platelet Activation Homo sapiens h sppaPathway,1/17,0.026035891626597,0.048687393848625,0,0,41.56875,151.654407895734,PRKCB,,,,,,,,,,
Oxidative Stress Induced Gene Expression Via Nrf2 Homo sapiens h arenrf2Pathway,1/18,0.02754681494067,0.048687393848625,0,0,39.121568627451,140.519524554554,PRKCB,,,,,,,,,,
Chaperones modulate interferon Signaling Pathway Homo sapiens h tidPathway,1/18,0.02754681494067,0.048687393848625,0,0,39.121568627451,140.519524554554,JAK2,,,,,,,,,,
METS affect on Macrophage Differentiation Homo sapiens h etsPathway,1/18,0.02754681494067,0.048687393848625,0,0,39.121568627451,140.519524554554,HDAC5,,,,,,,,,,
T-Cell Acute Lymphoblastic Leukemia,2/103,0.011081566043114,0.048694958477916,0,0,13.5664049163537,61.0823619126025,EP300;JAK2,,,,,,,,,,
COPS5,2/132,0.017739783250802,0.049251240341041,0,0,10.5246684350133,42.434889748997,GFI1B;MAX,,,,,,,,,,
Epidermal growth factor receptor (EGFR) pathway,2/111,0.012780541205787,0.049296373222322,0,0,12.5656437836128,54.784089372696,PRKCB;PRKCD,,,,,,,,,,
Nitric Oxide Signaling Pathway Homo sapiens h nos1Pathway,1/19,0.029055470008619,0.049419178046038,0,0,36.9462962962963,130.736261970552,PRKCB,,,,,,,,,,
Regulation of PGC-1a Homo sapiens h pgc1aPathway,1/20,0.030561860107419,0.049419178046038,0,0,35,122.080085720138,HDAC5,,,,,,,,,,
EGF Signaling Pathway Homo sapiens h egfPathway,1/20,0.030561860107419,0.049419178046038,0,0,35,122.080085720138,PRKCB,,,,,,,,,,
Downregulated of MTA-3 in ER-negative Breast Tumors Homo sapiens h mta3Pathway,1/20,0.030561860107419,0.049419178046038,0,0,35,122.080085720138,CDH1,,,,,,,,,,
Leptin -> NO Production/Vasodilation,1/8,0.012334969042911,0.049448077654477,0,0,95.0571428571429,417.80627965005,JAK2,,,,,,,,,,
non-Genomic Rapid Actions of Vitamin D in Vitamin D Biology,1/8,0.012334969042911,0.049448077654477,0,0,95.0571428571429,417.80627965005,VDR,,,,,,,,,,
CXCR4 -> ARRB1 Signaling,1/8,0.012334969042911,0.049448077654477,0,0,95.0571428571429,417.80627965005,ARRB1,,,,,,,,,,
HGFR -> STAT Signaling,1/8,0.012334969042911,0.049448077654477,0,0,95.0571428571429,417.80627965005,JAK2,,,,,,,,,,
IL31R -> STAT Signaling,1/8,0.012334969042911,0.049448077654477,0,0,95.0571428571429,417.80627965005,JAK2,,,,,,,,,,
IL6R -> STAT Signaling,1/8,0.012334969042911,0.049448077654477,0,0,95.0571428571429,417.80627965005,JAK2,,,,,,,,,,
NOTCH -> EP300/ASCL Signaling,1/8,0.012334969042911,0.049448077654477,0,0,95.0571428571429,417.80627965005,EP300,,,,,,,,,,
Dentin Formation in Rothmund-Thomson Syndrome,1/8,0.012334969042911,0.049448077654477,0,0,95.0571428571429,417.80627965005,EP300,,,,,,,,,,
Mantle Cell Lymphoma,2/105,0.011496181765015,0.049448077654477,0,0,13.301640441915,59.4016720326606,PRKCB;JAK2,,,,,,,,,,
Breast Cancer,2/108,0.012130805822615,0.049448077654477,0,0,12.9232270657124,57.0173699052305,EP300;JAK2,,,,,,,,,,
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha),2/112,0.01300045273167,0.049599553356697,0,0,12.4507836990596,54.0709035784678,CHD9;EP300,,,,,,,,,,
PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase Homo sapiens h myosinPathway,1/21,0.032065988516399,0.049735002596864,0,0,33.2483333333333,114.37291539919,PRKCB,,,,,,,,,,
Hypoxia and p53 in the Cardiovascular system Homo sapiens h p53hypoxiaPathway,1/21,0.032065988516399,0.049735002596864,0,0,33.2483333333333,114.37291539919,EP300,,,,,,,,,,
PRKACG,2/176,0.030298045372331,0.049902662966192,0,0,7.84581847007531,27.4342543711065,VDR;EP300,,,,,,,,,,
Polycystin-1 multiprotein complex (ACTN1, CDH1, SRC, JUP, VCL, CTNNB1, PXN, BCAR1, PKD1, PTK2, TLN1) (human),1/11,0.016922534733464,0.019149184040499,0,0,66.53,271.383130357804,CDH1
pRb2/p130-multimolecular complex (RB2, E2F4, HDAC1, SUV39H1, P300) (human),1/5,0.007726694289036,0.010382745450892,0,0,166.375,809.093962505696,EP300,,,,,,
G protein complex (Hdac5, Gnb1, Gng2) (mouse),1/3,0.004642963713238,0.00907488362133,0,0,332.783333333333,1787.84597380293,HDAC5,,,,,,,,
Fatty acid, triacylglycerol, and ketone body metabolism,3/173,0.002392768780112,0.022578869550603,0,0,12.4783613445378,75.3107053610453,PRKAB2;CHD9;EP300,,,,,,,,
Fatty acid, triacylglycerol, and ketone body metabolism Homo sapiens R-HSA-535734,3/217,0.004526175739854,0.03922685641207,0,0,9.89068758344459,53.3887239577775,PRKAB2;CHD9;EP300,,,,,,,,
Human betaherpesvirus 6 U69, ganciclovir kinase, phosphotransferase (gene: U69),8/538,1.18955801167143E-06,0.000431922664296,0,0,12.7573420836751,174.034751599406,PRKAB2;PRKCB;CTR9;PRKCD;EP300;TLK1;STK4;JAK2,,,,,,,,
Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes,,,,,,,,,,
